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Abbreviations 
AA Acetaldehyde-Adducts 
AcHO Acetaldehyde 
ADH Alcohol dehydrogenase 
ALDH Aldehyde dehydrogenase 
amu Atom mass unit (defined as 1/12 of the mass of a 12C-atom) 
Arg Arginine 
AUC Area under the curve 
BAC Blood alcohol concentration 
BOC tert-butyloxycarbonyl group (protecting group for amino groups) 
BSTFA N,O-bis(trimethylsilyl)trifluoroacetamide 
CDT Carbohydrate-deficient transferrin 
CYP Cytochrome P 450 
Cys Cysteine 
d5-EtG Ethyl-glucuronide where all hydrogen atoms of the ethyl group are 
replaced by deuterium molecules 
ECD Electron-capture detection 
EDTA ethylenediamine tetra-acetic acid (used as anticoagulating agent ex 
vivo) 
ESI Electrospray ionisation 
EtG Ethyl-glucuronide 
EtLys Ethyl-lysine 
EtOAc Ethyl acetate 
EtOH Ethanol 
FID Flame ionisation detection 
GC Gas chromatography 
GC-MS Gas chromatography - mass spectrometry 
GSH Glutathione 
GSSG Glutathione disulfide 
gGT Gamma-glutamyl-transpeptidase 
Hb Haemoglobin 
HPLC High performance liquid chromatography 
IS Internal standard 
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LC-MS Liquid chromatography mass spectrometry 
Lys Lysine 
m/z Mass to charge ratio 
MCV Mean corpuscular volume 
MEOS Microsomal ethanol oxidising system 
Met Methionine 
MS2 Mass spectrometry of specified peaks of a mass spectrum 
MTBSTFA N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide 
NaCNBH3 Sodium cyano borohydride 
NAD Nicotinamide adenine dinucleotide (oxidised form) 
NADH Nicotinamide adenine dinucleotide (reduced form) 
NADPH Nicotinamide adenine dinucleotide phosphate (reduced form) 
NAPQI N-acetyl-p-benzoquinoneimine 
o.c. on column 
PEth Phosphatidyl-ethanol 
PFAA Pentafluoro propionic acid anhydride 
PITC Phenyl-isothiocyanate 
SAH S-adenosyl-homocysteine 
SAM S-adenosyl-methionine 
SepPak Solid phase extraction cartridges (brand name) 
SRM Single reaction monitoring 
TBDMS tert-butyl-dimethyl-silyl group 
TFAA Trifluoro acetic acid anhydride 
TMCS Trimethylchlorosilane 
TMS Trimethyl silyl group 
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Summary 
In the course of the present doctoral studies two projects related to research in 
alcoholism and relevant for the postgraduate formation of a pharmacist were pursued: 
one project dealt with the development of analytical tools applicable to the identification 
of subjects abusing ethanol. The other, more pathophysiologically oriented project, 
addressed aspects of glutathione turnover of toxicological relevance for alcoholics. 
 
The aims of the first project were to establish analytical tools for the measurement of 
direct metabolites of alcohol, in particular of ethyl-glucuronide and ethyl-lysine for 
subsequent clinical studies using these metabolites as markers for excessive alcohol 
consumption. Several approaches to measure these metabolites were explored and 
adapted to locally available instruments. As proof of principle the present work 
demonstrates that ethyl-lysine is detectable by a chromatographic method in animals and 
humans consuming alcohol. Future studies will have to demonstrate the potential clinical 
utility of this marker of alcohol exposure for the identification of subjects consuming 
excessive amounts of alcohol. 
 
The aim of the second project was to estimate the contribution of methionine-derived 
cysteine to glutathione synthesis in humans. The project originated in the observation 
that subjects abusing alcohol are more susceptible to the hepatotoxic effects of 
paracetamol. Since methionine homeostasis is disturbed in chronic alcoholics as evidenced 
by higher circulating concentrations of methionine and homocysteine and by the impaired 
activity of several enzymes involved in the methionine cycle, an impaired ability to supply 
adequate amounts of cysteine generated from methionine via the transsulfuration 
pathway for the resynthesis of glutathione may be one explanation for the higher 
susceptibility of alcoholics. Prior to probing the methionine cycle, i.e. the formation of S-
adenosylmethionine from methionine, transmethylation and transsulfuration reactions and 
finally remethylation of homocysteine back to methionine, in alcoholic subjects, a 
quantitative analysis of the utilization of methionine for glutathione synthesis in healthy 
subjects under physiological conditions and in situations of a drug-induced stress on the 
glutathione pool was essential. The pharmacokinetic analysis of labelled methionine in 
healthy subjects shows that the stress on the glutathione pool stemming from the 
administration of two grams of paracetamol does not have a measurable effect on the 
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disposition of methionine. It is therefore unlikely that a potentially impaired utilization of 
methionine for glutathione synthesis in alcoholic subjects can be demonstrated by the 
present approach and different options to probe the methionine cycle in alcoholics will 
have to be explored.             
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Metabolites of ethanol as markers of alcohol 
abuse 
Introduction 
Problem 
Alcohol (ethyl-alcohol, ethanol) is together with nicotine one of the most abused, but 
nevertheless legal, substances. In 1999 each adult person (>15 y) in Switzerland 
consumed on average 11.45 L of pure alcohol consisting of 28% beer, 56% wine and 
16% spirits139. In 1998 the direct costs from alcohol consumption were at least 524 
million sFr.31. The total costs caused by alcohol consumption are estimated to be about 
6.5 billion sFr. a year11. In Switzerland only about 27% of women and 10% of men are 
complete teetotallers (all age groups), while 1% of women consume >40 g alcohol/d and 
5% of men more than 60 g alcohol/d and are therefore considered to be abusers39. The 
“limits” for alcohol abuse are gender specific because deleterious effects of alcohol tend 
to occur with a lower rate of consumption in women34,39. 
The illegal substances – the hard drugs like heroin, cocaine and ecstasy - are much more 
discussed in politics, but are far less used by the general population than alcohol130. 
 
Classification 
The term “alcoholism" is not easily defined. The National Council on Alcoholism and Drug 
Dependence (USA) has proposed the following definition: “Alcoholism is a primary, 
chronic disease with genetic, psychosocial, and environmental factors influencing its 
development and manifestations. The disease is often progressive and fatal. It is 
characterized by continuous or periodic: impaired control over drinking, preoccupation 
with the drug alcohol, use of alcohol despite adverse consequences, and distortions in 
thinking, most notably denial”79. Important is, that alcoholism is considered to be a 
disease that is classified as such as well in the 10th edition of the International 
Classification of Diseases (ICD 10) of the WHO as in the 4th Diagnostic and Statistical 
Manual for psychic diseases (DSM-IV) of the American Psychiatric Association117. 
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Since there are many reasons for excessive drinking, varying susceptibilities, and different 
drinking patterns subclassifications have been proposed: 
Jellinek distinguished the way of, the dependence and the self-control in drinking. He 
described 5 different drinking types that experience distinguishable problem patterns117. 
Cloninger proposed a simpler approach, only distinguishing 2 types. One is supposed to 
be related mostly to environmental factors, the other to genetic / hereditary factors. 
These types were refined by other authors with relation to the onset of the disease117. 
 
Consequences of excessive alcohol consumption 
A beneficial effect of moderate alcohol consumption (e.g. one glass of wine or beer a 
day18,23,97) has been well documented particularly in regard to cardiovascular function. In 
contrast, a consumption of >40 g/day in women and of >60 g/day in men over a 
prolonged period of time is associated with medical, social and psychic 
problems34,59,92,104,108,124,135. 
 
Clinical features and effects of alcohol vary with its concentrations. Typical clinical signs of 
acute alcohol intoxication are summarised in table 1. These signs are dependent on a 
number of factors including the rate of intake, the degree of individual tolerance and the 
nutritional status. 
 
Table 1: Clinical features and effects of various alcohol concentrations111 
Blood alcohol concentration 
(mg/L) Clinical effects 
 2 Euphoria 
 3 Increased likelihood of having an accident 
 4 Disinhibited 
 8 Impaired coordination, legal limit for driving in UK 
 15 Loss of self-control, slurred speech, drowsiness, amnesia 
 30 Stupor, coma 
 50 Coma, death possible 
 60 Death certain 
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Medical problems associated with excessive alcohol consumption 
As an overview the relative risk attributed to increasing alcohol consumption for selected 
organs or groups of organs is depicted in figure 1. 
 
 
Fig. 1: Cause specific relative risks by alcohol consumption. When men and women are not shown 
separately, same model is used for both138. 1 unit corresponds to 9 g of pure alcohol. 
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Alcoholic Liver disease108 
The liver is the major target of adverse effects of excessive alcohol consumption.  
Following the consumption of moderate amounts of alcohol the liver accumulates 
triglycerides. The cause for these changes is the disturbed balance of NAD/NADH2. When 
such a fatty liver is further stressed with alcohol an inflammatory reaction ensues with the 
development of an alcoholic steatohepatitis.  The continuous stimulation of myofibroblasts 
will lead to the deposition of fibrous tissue and eventually cirrhosis of the liver will occur 
with all its deleterious consequences (figure 2). Alcoholic hepatitis carries a mortality of 
between 15 – 25% 108. Cholestasis quite often aggravates the existing liver disease and 
worsens the prognosis.  
 
Alcohol
fatty liver
Cirrhosis
hepatocellular
Carcinoma
alcoholic
Hepatitis
 
Fig. 2: scheme of evolving alcoholic liver disease 
 
The relative risk to develop cirrhosis of the liver is – depending on the amount of alcohol 
consumed – between 1.30 (♀ <20 g/day; ♂ <40 g/day) and 13.00 (♀ >40 g/day; ♂ >60 
g/day) 34. 
 
Pancreas 
Besides the liver the pancreas is the organ that is most often damaged by alcohol. Alcohol 
consumption is a frequent cause of acute pancreatitis, and 1-3% of patients with long-
time alcohol consumption develop a manifest chronic pancreatitis16. Alcoholic pancreatitis 
develops in three phases: a subclinical phase first which varies in duration between 3 and 
20 years, eventually followed by repeated painful attacks of pancreatitis over a period of 5 
to 10 years. In the third phase the course is characterized by pancreatic calcifications, 
pain and irreversible and progressive exocrine and endocrine insufficiency of the gland16. 
60–80% of all cases of chronic pancreatitis are thought to be related to excessive alcohol 
consumption16. 
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The mechanisms by which the pancreas is damaged by excessive alcohol consumption are 
not fully understood yet. Studies have been carried out to determine the metabolites of 
alcohol responsible for the development of pancreatitis. One possibility is a direct toxic 
effect of alcohol itself141. Another possibility is that acetaldehyde (AcHO) is 
responsible7,43,47. Non-oxidative metabolites of alcohol like fatty acid ethyl esters or 
phosphatidylethanol have also been discussed60.  
 
Brain104 
The central nervous system is affected by alcohol consumption. About 7% of all cases of 
dementia are attributable to excessive alcohol consumption. One possible cause for this 
could be a lack of thiamine due to alcohol generated malnutrition or malabsorption. 
Another reason for brain injury may be a dose-dependent direct neurotoxic effect of 
alcohol on N-methyl-D-aspartate (NMDA) receptors resulting in organic brain syndrome 
like the Wernicke encephalopathy or the Korsakoff psychosis. Luckily, just a few alcoholics 
develop such a syndrome. But many suffer from memory deficits and difficulties to 
concentrate. These symptoms may persist even after withdrawal. A further affection of 
the brain caused by chronic alcoholism is the markedly increased risk of seizures34. 
Addiction phenomena which are of great importance in the context of alcoholism are also 
based in the brain.  
 
Heart34 
The protective effect of moderate alcohol consumption for coronary heart diseases (CHD) 
is associated with an increase of the high-density lipoprotein (HDL) fraction and changes 
in the viscosity of the blood18,97,137. Depending on the population the protective effect is 
more or less pronounced. Young people and female gender benefit less than people of 
older age and males. Mediterranean people tolerate higher amounts of alcohol to still 
experience lower relative risks for CHD. The pattern of consumption apparently plays an 
important role: in the Mediterranean people tend to drink alcohol, especially wine, in small 
amounts on a daily basis, whereas in other populations like the USA or the UK there is a 
tendency to only consume at weekends, resulting in the same average daily quantity, but 
with much higher alcohol peak concentrations. The protective effect seems not to be 
drink-specific. The benefits in the reduction of CHD is a direct alcohol effect and 
independent from the type of alcoholic beverage34,58. 
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On the other hand, even low doses of alcohol have a cardio depressive effect by 
decreasing the contractility of the heart (negative inotropic effect), eventually leading to 
alcoholic cardiomyopathy. Alcohol also increases the heart-frequency and arrhythmias 
may occur. Heavy consumption (70–100 g/d) may lead to systolic hypertension which is 
due to multifactorial changes e.g. the sympathetic nervous system has an increased 
activity, there is more antidiuretic hormone released into the blood and the metabolism of 
electrolytes is disturbed.  
 
Drug Interactions92 
In social drinkers alcohol dehydrogenase (ADH) is the most important metabolic pathway 
for the elimination of alcohol. In alcoholic subjects the metabolism of alcohol via the 
microsomal ethanol oxidising system (MEOS), i.e. cytochrome P450 (CYP) isoenzyme 2E1, 
is induced and gains more importance92. This may lead to a faster elimination of alcohol 
and increase the tolerance towards alcohol in habitual drinkers92. 
 
Since some drugs and toxins are metabolised by CYP 2E1 its induction may result in 
relevant pharmaco- and toxico-kinetic interactions. For example, AcHO, chlorzoxazone, 
carbon tetrachloride, and paracetamol are substrates of CYP 2E1 as well. Other 
substances like isoniazid also induce the CYP 2E1. Induction of CYP 2E1 by alcohol may in 
part be responsible for the increased susceptibility of alcoholics to the hepatotoxicity of 
paracetamol, whose toxic metabolite is formed by this isozyme. Disulfiram and some 
antibiotics (metronidazol, chloramphenicol, griseofulvin) inhibit the aldehyde-
dehydrogenase (ALDH). When alcohol is consumed in the presence of these compounds 
the elevated levels of AcHO lead to flushes with red face, weakness and nausea. H2-
blockers and acetylsalicylic acid inhibit the alcohol-dehydrogenase in the stomach 
resulting in higher blood-alcohol concentrations due to the inhibition of presystemic 
metabolism. 
 
Pharmacodynamic interactions are common with drugs affecting the central nervous 
system and may e.g. increase the sedating effect of alcohol itself. 
 
Psycho-Social consequences of excessive alcohol consumption 
Alcoholic beverages are often used as soporifics, but they may also disturb the sleep 
rhythm59. A nightly withdrawal can lead to tachycardia and sweating in the second half of 
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the night. An increased day-sleepiness can result. Alcohol relaxes muscles and this affects 
also the respiratory tract, leading to snoring and sleep apnoea. An alcoholic experiences a 
prolonged sleep-latency, reduced sleep-efficiency and –duration and the deep-sleep 
periods are shortened. Sleep-disorders might persist for months or years after the subject 
stops drinking. 
 
Alcoholism is a social problem as well. Within the family an alcohol-dependent person may 
lead to conflicts, violence, financial problems and lesser care-taking for children. All of 
these problems mentioned may furthermore be passed on over generations because 
children that grew up under such circumstances are prone to behave like their parents. An 
alcoholic person may loose employment which leads to additional stress. The subject may 
be tempted to alleviate the stress by consuming more alcohol so the alcoholic ends up in 
a vicious circle.  
Driving under the influence of alcohol is a risk for the general population and many work-
accidents may be related to alcohol consumption.   
 
Biological Markers of excessive alcohol consumption 
In clinical practice it would be helpful to identify subjects who consume excessive 
amounts of alcohol in order to institute measures to prevent the medical, social and 
psychological problems associated with alcoholism mentioned above. In patients 
presenting with a medical problem a simple test identifying alcohol as the potential cause 
would be a big advantage. Thus, there is a need for the development and validation of 
reliable markers of acute and chronic excessive alcohol consumption.  
 
Basically two types of markers may be considered: state markers that indicate a 
genetically determined increased vulnerability to alcohol and alcohol related problems; 
these markers are always present. On the other hand there are trait markers that become 
manifest when abuse or alcohol related problems occur, and that disappear when the 
subject reduces the alcohol consumption. For the detection of excessive alcohol 
consumption a lot of research has been done over the last 40 years63,64,65,66 but still no 
single trait marker is established that fulfils all requirements.  
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Metabolism of alcohol 
For the better understanding of potential trait markers a short overview of the metabolism 
of alcohol is given (figure 3).  
Due to its chemical properties (well soluble in water and fat) alcohol is readily absorbed 
from the stomach and small intestine. Already a few minutes after ingestion alcohol can 
be detected in blood. About 5-10% of an orally ingested dose are metabolised by ADH of 
the stomach. In addition to this gastric first pass effect which may vary considerably 
depending on the nutritional status of the subject, there is an equally variable hepatic first 
pass effect, so that only a fraction of an ingested amount of alcohol reaches the systemic 
circulation. Most of the metabolism of alcohol occurs in the liver. Approximately 5-10% 
are excreted unchanged via the lungs, the kidneys or the skin45,82,135. 
 
In the liver most of the ingested alcohol is oxidised by ADH to AcHO. AcHO itself is 
oxidised by ALDH to acetate, which is then coupled to coenzyme A and may undergo 
further oxidation in the Krebs cycle to yield CO2 and H2O or is utilized for the synthesis of 
fatty acids. All oxidation steps need coenzymes, mainly NAD, which is reduced to NADH2. 
The resulting shift in the NAD/NADH ratio in part explains the hypoglycaemia, 
hyperlipidaemia, fatty liver, hyperlactacidaemia and  hyperuricaemia that may be the 
results of alcohol abuse135. 
 
Approximately 3-8% of the ingested alcohol are metabolised via the MEOS, in particular 
the CYP 2E1, leading to AcHO as well82. As mentioned earlier, this enzyme-system, in 
contrary to ADH, may get induced when alcohol is consumed chronically1,82. Since the 
induction of the MEOS leads to a faster alcohol oxidation more AcHO is generated which 
leads to higher blood-AcHO concentrations and therefore more complications due to that 
toxic substance are expected92. 
 
The third pathway by which alcohol is oxidised to AcHO is by catalase. This pathway  is 
physiologically unimportant. 
 
The elimination of alcohol from the body follows zero order kinetics due to saturation of 
the enzymes involved. On average 0.1-0.2‰/h or roughly 4-10 g/h of alcohol are 
eliminated in men; women have a slightly lower elimination rate. 
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Fig. 3: pathways of alcohol metabolism135 
 
Ethanol 
After alcohol consumption, alcohol itself is detectable for at most 24 h in expired air, 
blood or urine. This is a short time interval and reflects only current consumption, but 
does not distinguish between chronic abuse and a binge. The National Council on 
Alcoholism (USA)101 has nonetheless suggested that a blood alcohol concentration (BAC) 
exceeding 1,5‰ without gross evidence of intoxication or a BAC greater than 3‰ at any 
time could be used as an indicator for alcohol abuse. 
 
Methanol 
The plasma concentration of methanol amounts to 0.5-1.0 mg/L; it may increase by 
eating fruits or drinking fruit-juices. After drinking alcoholic beverages, the metabolism of 
methanol is blocked at alcohol concentrations above 0.4 g/L, because both compounds 
compete for ADH and the affinity of methanol for the enzyme is approximately 10 times 
lower than that of ethanol45. Thus, during the metabolism of ethanol the concentration of 
endogenously produced methanol increases. Therefore blood methanol levels exceeding 
2.244 (or 1049,80) mg/L might be indicating alcohol abuse. 
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Congeners 
In alcoholic beverages there are congeners other than methanol like propanol, iso-
propanol, acetone, all forms of butanol and still higher alcohols80;81. Acetone and 2-
propanol are in a redox-equilibrium. The reduction of acetone to 2-propanol requires NAD 
and is catalysed by ADH. Thus, a rising level of 2-propanol compared to acetone might be 
an indicator for alcohol consumption. A cut-off value of the sum of both substances has 
been proposed as a marker for habitual drinking80. Physical activity also results in a rise of 
blood-acetone levels and so does stress at the dentist49. The levels found are much higher 
than after alcohol consumption, but there is no rise of 2-propanol. In some newly 
marketed sweetened alcoholic drinks (Alco pops) 2-propanol concentrations were found 
that exceed 1300 mg/L. As a consequence consumers will test positive for heavy drinking 
even though only one single drink was imbibed. 
 
The clinical utility of acetone and 2-propanol as alcohol markers is low, because – as 
stated above – metabolic disorders like stress, hunger or diabetes also influence these 
parameters. 
 
g-glutamyl-transpeptidase (gGT) 
The activity of the g-glutamyl-transpeptidase (gGT) is often elevated in serum of alcoholic 
patients. gGT is a sensitive marker for hepatobiliary diseases129. It is also a marker of 
enzyme induction as for instance in the case of administration of phenytoin96 where its 
synthesis increases. 
Due to these frequent conditions characterized by an elevated gGT the sensitivity and 
specificity of gGT as a marker for excessive alcohol consumption are only around 50%.  In 
known chronic alcoholic patients sensitivity and specificity may increase up to 90%3. In a 
study with healthy volunteers who consumed a daily dose of 60 g of alcohol for 3 weeks 
there was no increase in gGT111. If levels are elevated due to alcohol consumption 
normalisation occurs after 6-8 weeks of abstinence117. gGT is rarely elevated in subjects 
under the age of 30 years and is less sensitive in women111. 
 
When a drunken driver has an elevated gGT, this is likely due to alcohol abuse. More than 
40% of drunken drivers had gGT levels above the upper limit of normal (ULN) of 28 U/L, 
and 13% had levels even >70 U/L. So this marker has a certain importance in detecting 
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alcohol problems in drunken drivers49. In spite of its drawbacks gGT is considered as the 
reference biological marker for alcohol abuse.  
 
Mean corpuscular volume (MCV) 
The mean corpuscular volume (MCV) of red blood cells is often increased in alcoholics. It 
correlates with both the amount and frequency of drinking because it reflects a direct 
toxic effect of alcohol on the bone marrow or erythrocytes. In addition, a deficiency in 
folic acid, which may be associated with heavy consumption of alcohol, may contribute.  
It is a trait marker that rises slowly – at least one month of drinking 60 g of alcohol daily 
are required - and due to the long half live of the red blood cells remains elevated for a 
long time (up to 3-4 months). The sensitivity is rather low even in hospital environments 
(40-50%), but the specificity is high (80-90%), and only a few teetotallers and social 
drinkers will have elevated MCV values111. Since MCV is also affected by a lack of vitamin 
B12, by liver diseases, reticulocytosis and anticonvulsants20,101,111 the specificity will be 
lower in some patient populations. An advantage of this marker is its analysis: it is 
inexpensive and can be easily determined, which increases its availability. A MCV >98 fL 
bears a 60% probability that the subject is consuming >450 g of alcohol per week21,109,117.  
 
In combination, the specificity of MCV and gGT as alcohol markers can be increased. 
When the cut-off for MCV and gGT were set at >98 fL and  >50 U/I, respectively, a high 
specificity (98%) was achieved, but a very low sensitivity (17%) proved to be a 
problem20.  
 
Carbohydrate-deficient transferrin (CDT) 
The deficiency in the glucosylation of transferrin first observed in the late seventies by a 
Swedish group in the cerebrospinal fluid and the serum of alcoholics has been studied 
world wide (there are more than 200 studies published at present, including some 
reviews). Transferrin is the major iron transport protein in the body. The protein has two 
“pockets” where iron – as Fe3+ – may be transported. The protein also carries “antennae” 
of N-glycans that themselves carry sialic acid residues. The most important transferrin 
form in healthy human is the tetrasialo transferrin (64-80%). In alcoholics the 
glucosylation is hampered, so they have significantly higher amounts of carbohydrate-
deficient forms of transferrin. The term carbohydrate-deficient transferrin (CDT), as it is 
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used nowadays, includes the three forms of transferrin: asialo, mono- and 
disialotransferrin. 
 
The pathomechanisms underlying an increased CDT in alcoholics are not fully understood 
yet. One cause could be that alcohol or even more so AcHO affects N-glycan synthesis in 
the Golgi apparatus. Another hypothesis is a reduction of mRNA of sialyltransferase, so 
that there is a lack of enzymes to sialylate the transferrins. Still another idea deals with an 
increased activity of the sialidase which cleaves the carbohydrates from the protein. 
The analysis of CDT is delicate. The concentrations of the CDT-isoforms are low and all 
the isoforms have very similar chemical and physical properties. However, the isoelectric 
point (pI) of the isoforms varies not only with the increase in glycosylation, but also with 
the load of iron of the protein. There is no standard analytical procedure established. So 
the assessment of CDT as a marker of alcohol abuse has to take into account not only the 
reported value, but also the cut-off/borderline values and the analytical method used. 
Although false positive increases in CDT are found in patients with liver disease CDT 
seems to be a rather specific marker for chronic alcohol abuse, whereas the sensitivity is 
not very high (gGT has the best sensitivity, but a lack in specificity). A rise in CDT occurs 
after a daily consumption of 50-80 g of alcohol for at least one week. It remains elevated 
for about a week upon abstinence 3,8,9,54. 
 
Aminotransferases 
The aminotransferases – they are also known as transaminases – are a group of enzymes 
that catalyse a reversible reaction in which a a-ketoacid is converted into an amino acid. 
The most important enzymes of this group are the alanine-aminotransferase (ALT) – also 
known as ALAT or GPT (glutamate-pyruvate-transaminase) – and the aspartate-
aminotransferase (AST) – also known as ASAT or GOT (glutamate-oxalate-transaminase). 
ALT is a more or less liver-specific enzyme with a half-life of approximately 47 h. A rise of 
its activity in serum generally reflects hepatocellular injury of any origin. AST is a non-liver 
specific enzyme, that is found in several organs such as muscle (heart and skeletal), 
kidney, pancreas, brain, lungs and liver. Its activity is high in skeletal muscle and liver. Its 
half-life in plasma is approximately 17 h. A parallel rise of AST and ALT is an indicator of 
hepatocellular injury.  
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These enzymes are clinically helpful in the assessment of alcoholic liver disease. However, 
in order to identify alcohol abuse these enzymes are of limited value since many 
alcoholics do not have liver injury and thus elevated transaminases. Only when fatty liver 
or an alcoholic hepatitis ensues from the consumption of alcohol will the transaminases in 
serum increase. The two enzymes may be of use in distinguishing alcoholic from non-
alcoholic liver disease. An AST/ALT ratio >2 is a strong indicator of an alcoholic origin101 
(sensitivity ~50%; specificity 80%20,95) whereas with a ratio of ≤1 it is more likely that the 
disease is not alcohol related128.   
 
Since alcohol consumption results in mitochondrial injury, the mitochondrial isoform of 
AST (mAST) in serum increases more than AST. The two forms can be determined 
immunologically. The ratio of mAST to total AST has a sensitivity for excessive alcohol 
consumption of about 90%20,73,111. Unfortunately, the ratio does not allow a differentiation 
of alcoholic and non-alcoholic fatty liver disease95. With the probably increasing 
prevalence of non-alcoholic steatohepatitis the predictive value of the ratio of AST/ALT  or 
mAST/AST is likely to be lower than what has been reported in the literature. 
 
Ethyl-glucuronide (EtG) 
Ethyl-glucuronide (EtG) is a minor metabolite of ethanol postulated in 190283, first found 
in rabbits in 195255 and then in humans in 196751. EtG is a non-volatile, water-soluble, 
stable upon storage, direct metabolite of ethanol that can be detected in body fluids and 
hair samples only after ethanol has been consumed. A minor fraction of a dose of ethanol 
undergoes conjugation with uridinediphosphate-glucuronic acid to produce EtG (0.5 - 1% 
in rabbits55, 0.013 – 0.04% in humans24,35). EtG is a marker of alcohol consumption that 
can be detected in body fluids for an extended time period after complete elimination of 
alcohol from the body. EtG peaks about 2–3.5 h after the blood alcohol concentration has 
reached its maximum107 and is then detectable – depending on the amount of ethanol 
consumed – for up to 36 h in serum or up to 80 h in urine5,149. The terminal half-life is 
between 2 and 3 h24,29,107,119. 
 
It is surprising that a hydrophilic carboxylic acid is deposited in hair but EtG is detectable 
in hair of chronic alcoholics who consume at least 10 g/day over some time105. 
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With its specific time frame of detection intermediate between short- and long-term 
markers, EtG is a promising marker of alcohol consumption in general and of relapse 
control147 with a sensitivity of 77% and a specificity of 71%105.  
 
Acetaldehyde-Adducts 
AcHO is a reactive molecule generated by the oxidation of ethanol. The electrophilic 
carboxy-group of the molecule has the ability to react with amino- and sulfhydril-groups. 
Identified targets include the e-amino-group of lysine46, which is thought to be one of the 
most important targets68; a-amino-groups of terminal amino acids in proteins46,127, as 
described for valine in the b-chain of haemoglobin103, and the sulfhydril-groups of cysteine 
(Cys) and reduced glutathione (GSH) which serves as scavengers and may inhibit 
detrimental adduct-formation27. The spectrum of chemical reaction products is not fully 
understood, but investigators have found Schiff bases (unstable to clean-up procedures 
like acid-precipitation, gel-filtration or dialysis27) that could be stabilised into secondary 
amines like e-ethyl-lysine (EtLys) through a reduction step46,127,131. Also ring formation e.g. 
with a terminal valine resulting in imidazolidinones103 has been described. Among the 
biological structures affected are albumin27,46,68,78,131,132,140,144, 
haemoglobin17,38,50,69,70,84,103,120,122, tubulin, collagen, the family of the cytochrome 
isoenzymes (especially CYP 2E112,70 and CYP 3A412,87), nucleosides, low density 
lipoproteins and probably most of the plasma proteins and enzymes.  
 
Even if nearly the total dose of ethanol imbibed (46 g @ 1 mol) is converted to AcHO the 
blood AcHO concentrations in Caucasians only reach levels of up to 50 µM38,120. This is 
first because the ALDH removes the generated AcHO very rapidly, and on the other hand 
adduct formation may account for this effect. 
 
A loss of function is expected for all of the affected structures and protein unfolding due 
to AcHO-adducts (AA) cannot be ruled out70. However the oxygen affinity in haemoglobin 
is not changed120. AA might serve as direct, stable and long-lasting markers for excessive 
alcohol consumption. Depending on the protein affected one could expect varying ‘half-
lives’ of AA, and therefore with one single method alcohol consumption over different time 
intervals could be traced. In the hope of finding a marker similar to HbA1c which is used to 
follow diabetic patients haemoglobin adducts with AcHO have been studied 
extensively50,69,113. 
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The analysis of AA is difficult because the amount of adducts generated is likely to be very 
small. Immunologic methods of detection that may miss some adducts and may have the 
drawback of cross-reactivity of the antibodies have been used70,71,142,. 
 
Other Markers 
b-Hexosaminidase (HEX) 
b-Hexosaminidase (HEX) is a lysosomal enzyme that is readily removed from the 
circulation by non-parenchymal cells in the liver. Its activity in plasma reflects excessive 
alcohol consumption (more than 60 g of alcohol daily for more than 10 days111). It returns 
to base-line values after 7–10 days of abstinence95. HEX is also found in urine, where it is 
a sensitive marker of renal disease, but elevated urinary HEX levels are also found in 
about 80% of alcoholics81. Although the activity of the enzyme is influenced by 
hypertension, diabetes, pregnancy, myocardial infarction, and also by using oral 
contraceptive pills56,111, HEX may be a useful marker to discriminate between alcoholics 
and non- or social-drinkers. 
 
Dolichols 
Dolichols are long-chain polyprenols containing a a-saturated isoprene unit. They act as 
glycosyl carrier lipids in the synthesis of N-linked glycoproteins. Elevated concentrations  
of dolichols in blood and urine have been found in alcoholics80,81. It has been postulated 
that alcohol interferes with their catabolism, because dolichols are also oxidised by ADH. 
Dolichols may also be elevated in Alzheimer’s Disease, ceroid lipofusinosis and advanced 
age101. Formal studies assessing sensitivity and specificity of dolichols as markers for 
alcohol consumption or alcoholism are not available. 
 
Salsolinol 
There is a class of substances (the 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines (TIQs)) 
which are formed by cyclisation of catecholamines with AcHO, the first metabolite of 
alcohol oxidation. The most important among them is salsolinol which is formed with 
dopamine. Norsalsolinol is the condensation product of dopamine and formaldehyde 
which has a much higher propensity to form such ring structures. Salsolinol has been 
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found in urine, cerebro-spinal fluid, brain homogenates as well as in plasma. Elevated 
levels of salsolinol are frequently found in alcoholics, but it failed to distinguish alcoholics 
from non-alcoholics80. Furthermore, its analysis is rather complicated and there is only few 
data on how much alcohol would be needed to get a rise of the marker substance. Near 
to nothing is known about the influences of dietary conditions that might further affect 
the result80,102. 
 
Phosphatidylethanol (PEth) 
Phosphatidylethanol (PEth) is an “aberrant” phospholipid of cell membranes (brain, lung, 
heart, adipose tissue, neutrophils) which is synthesized by phospholipase D in the 
presence of alcohol. The marker only reacts to a single dose of much more than 60 g of 
alcohol or a 3 week-load of 750–1000 g alcohol (40–50 g daily). Single doses of 32–47 g 
alcohol could not be detected. The half-life is about 4 days, so in heavy consumers levels 
might be detectable up to 3 weeks. No correlation was found with gGT and CDT, and it 
seems, that PEth is more sensitive in detecting alcohol abuse than CDT42,80,102. Since the 
method of analysis has been improved with the advent of HPLC134 it is well possible that 
PEth will prove to be a reliable marker of alcohol consumption. Its sensitivity and 
specificity still has to be established. 
 
5-OH-Tryptophol (5-HTOL) 
A metabolic interaction between alcohol and serotonin might be used for the detection of 
recent alcohol consumption. Under normal conditions 5-hydroxytryptophol (5-HTOL) is 
only a minor metabolite of serotonin in urine and serum. After alcohol consumption 5-
HTOL increases markedly probably due to inhibition of ALDH or the increase in the 
NAD/NADH ratio, and the concentration of the normal serotonin metabolite 5-
hydroxytryptophol-3-acetic acid (5-HIAA) decreases correspondingly. To exclude 
variations by diluting or due to dietary sources of serotonin such as bananas, tomatoes or 
walnuts80 the ratio of 5-HTOL and 5-HIAA is used. The ratio remains elevated for 6 –15 h 
after blood alcohol has returned to normal. The marker has a high sensitivity (as little as 
20 g/day of alcohol can be detected) and a high specificity for very recent alcohol 
consumption. This marker is not influenced by heavy long time consumption, but reflects 
only the alcohol intake of the preceding day (~24 h)45,81,111. Since 5-HTOL is not formed in 
the urine after death this marker distinguishes between alcohol intake before death and 
alcohol formation after death in forensic practice80. 
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Fatty Acid Ethyl Esters (FAEE) 
Fatty acid ethyl esters (FAEE) are formed by enzymatic esterification of alcohol with fatty 
acids. They have been detected in high concentrations in organs commonly damaged by 
alcohol abuse, in particular the pancreas and the liver60. The rate of synthesis of FAEE in 
these organs proved to be high. FAEE are supposed to contribute to the end organ 
damage after chronic heavy alcohol consumption. Possible mechanisms involve decreased 
rate of cell growth and protein synthesis, disruption of oxidative phosphorylation in 
mitochondria and changes in membrane fluidity, which could account for increased 
fragility of pancreatic lysosomes28,61. 
 
FAEE are formed after alcohol ingestion and reach their concentration maximum in a 
similar time frame as the blood alcohol concentration. Over the first hours their decay 
parallels that of alcohol, but since they may accumulate in several tissues they have a 
secondary elimination phase which is much slower than that of alcohol itself. Therefore 
FAEE are still detectable (>24 h) when alcohol is no longer present in the blood28,61. FAEE 
are accumulated in sebum and so deposited in hair, which allows detection of heavy 
drinking for as long as 2 months125. A positive testing in hair specimens may also be 
caused by daily use of alcoholic hair lotions as it has been found in an alcohol abstaining 
hairdresser10. 
Analytically FAEE are now well accessible by GC-MS150. FAEE in blood proved to have a 
high specificity and sensitivity28. 
 
Questionnaires 
For screening purposes there are several questionnaires, some of them with good 
validation for the use in primary care. 
 
MALT 
The Munich Alcoholism Test (MALT) consists of 31 questions that have been selected from 
over 1000 alcohol related questions. The test reflects amounts consumed, symptoms of 
alcoholism and biological abnormalities. It is a combination of clinical questions asked by 
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the physician (MALT-F) and 24 questions concerning alcohol habits filled in by the patient 
(MALT-S). The rating of the MALT-F answers is higher than for MALT-S answers. 
It seems to be a cheap and fast way to identify alcoholism. Sensitivity and specificity are 
90% and 85% respectively. One drawback of MALT: it is only available in German3,117. 
 
CAGE 
This is the shortest of all the questionnaires and the name is an acronym for its four 
questions: 
· Have you ever felt you should Cut down on your drinking? 
· Have people Annoyed you by criticizing your drinking? 
· Have you ever felt bad or Guilty about your drinking? 
· Have you ever had a drink first thing in the morning to steady your nerves or to get 
rid of a hangover (Eye opener)? 
In different studies one or two positive answers have been considered as a positive test, 
giving evidence for alcohol dependence. Already one positive answer requires a more 
detailed clinical assessment30,111. The sensitivity and specificity are in a range of 60-95% 
and 40-95%, respectively. The T-ACE Test asks two questions differently and is used to 
detect alcohol consumption during pregnancy. If 2 of the four questions are answered 
affirmatively (cut-off) 70% of the heavy drinkers in pregnancy are discovered. 
 
MAST 
The Michigan Alcoholism Screening Test asks 25 questions that try to discover drinking 
problems, help seeking behaviour and alcohol related disabilities. The sensitivity and 
specificity of the questionnaire are reported to be both as high as 85%. A variant of this 
test has been introduced: The Self-Administered Alcoholism Screening Test (SAAST), 
which includes 35 questions111. 
 
AUDIT 
The WHO constructed a questionnaire (Alcohol Use Disorders Identification Test = 
AUDIT) that contains 10 questions that deal with intake, dependence and adverse 
consequences4. With exception of the last two items the questions allude to the previous 
year, and responses are weighted between 0 and 4 points, generally based on the 
frequency at which the respective topic in question occurred. The reported sensitivity and 
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specificity varies considerably depending on the chosen cut-off limits. When a cut-off of 8 
points is used the sensitivity is in the range of 83-96% and the corresponding specificity 
between 66 and 100%. 
 
Other instruments 
There are other instruments to determine alcohol abuse such as the Alcohol-Clinical-
Index114. It consists of 17 clinical symptoms that are closely related to alcohol 
consumption like spider naevi or palmar erythema, but also of signs that are highly 
correlated to alcoholism like cigarette burns. In addition, anamnestic information is 
included like early morning tremor, hallucinations or inability to concentrate. With this 
Alcohol-Clinical-Index the sensitivity to distinguish alcoholics from social drinkers is 
88%114,117. In another patient sample the distinction between alcoholics and non-
alcoholics was less favourable6.  
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Ethyl-Glucuronide (EtG) 
Ethyl-glucuronide (EtG) is a known marker of recent alcohol consumption. Its metabolism 
has not been fully elucidated by now. The original aim of this work was to investigate 
whether a metabolic activation of EtG could contribute to the toxicity of alcohol. A similar 
activation to toxic metabolites is known from glucuronides of diclofenac110 and 
zomepirac116. As a first step a method to analyse EtG in our laboratory was to be set up. 
 
Possible analytical approaches 
EtG contains ethanol (EtOH) and analytical methods have been developed for the 
sensitive and accurate quantification of EtOH in a biological matrix. Thus, a simple 
approach would be the analysis of EtG via its content of EtOH provided that EtOH can be 
quantitatively liberated from the glucuronide. 
EtG does not absorb any light in the range of wavelengths suitable for analysis by HPLC 
as shown in figure 4. 
 
Fig. 4: uv spectrum of a 250 µM aqueous solution of EtG 
 
For HPLC analysis the compound therefore has to be derivatised with a chromophore or a 
mode of detection such as mass-spectrometry must be used that does not depend on the 
absorption of light. Few chromophores suitable for the derivatisation of glucuronides and 
HPLC analysis are available leaving mass-spectrometry as the most promising approach. 
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Theoretically, EtG should also be amenable to determination by GC if one succeeds in 
making the compound sufficiently volatile by appropriate derivatisation. Several of the 
described approaches to the analysis of EtG have been explored as described in the 
following section. 
 
Hydrolysis of ethyl-glucuronide 
In view of the wide availability of gas-chromatographic methods to analyse EtOH the 
determination of EtG in form of EtOH after its hydrolysis would be an attractive analytical 
approach. 
 
Method 
1000 µL of 1 mM EtG (Medichem Inc. Stuttgart, D) in phosphate buffer (1 M, pH 5.5) was 
incubated with 20 µL of glusulase (b-glucuronidase EC 3.2.1.31 /arylsulfatase EC 3.1.6.1 
from Helix pomatia; Roche Diagnostics, Indianapolis IN, USA) or 20 µL of glucurase (b-
glucuronidase solution from bovine liver, Sigma, St. Louis MO, USA) at 37°C for 2 h in an 
20 mL ampoule flask . The enzymatic activity was stopped with 100 µL of 60% perchloric 
acid. 500 µL of n-propanol (100 µg/mL @ 1.67 mM in 0.9% sodium chloride solution) were 
added as internal standard (IS). 
To avoid matrix-effects from enzymes and glucuronic acid residues still present in the 
reaction mixture a head-space method was applied to analyse the resulting EtOH. Before 
injection samples were incubated at 60°C for 30 min. in a waterbath Büchi B 465. 1-5 mL 
of the head-space gas-phase was removed with a plastic syringe and immediately injected 
into the GC. A Perkin Elmer Sigma 3B Gas Chromatograph equipped with a Tenax 60-80 
packed glass column was used for analysis. Gas flows were as follows: nitrogen carrier 
gas 160 kPa, air 200 kPa and hydrogen 120 kPa. The oven temperature was set at 100°C, 
the injector at 180°C and the detector at 250°C. 
 
Results 
First experiments with liquid injections on GC resulted in chromatograms with many 
peaks, where the peaks of interest could hardly be seen. With the head-space technique 
most of the resulting matrix peaks were not present any longer. The EtOH and IS peaks 
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were well visible at 4.2 min and 11.7 min, respectively, and base-line separated from the 
few other peaks present. 
A calibration curve for the ratio of EtOH and IS is shown in figure 5. Different 
concentrations of EtOH were incubated at 37°C for 2 h, replacing the enzyme with 20 µL 
of a sodium chloride solution 0.9%. After the addition of 100 µL of perchloric acid 60% 
the samples were chromatographed with n-propanol as IS (1.67 mM). 
 
Ethanol - IS- Ratio
y = 0,4878x + 0,009
R2 = 0,9988
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Fig. 5: calibration curve of EtOH analysed by headspace GC. The EtOH peak area is set in relation to the peak 
area of the IS 
 
After incubation with glusulase we always recorded a peak after 4.2 min. where EtOH was 
eluted. In case of EtG or EtOH (as positive control) this was expected, but in case of a 
blank i.e. water or phosphate buffer incubated instead of EtG no EtOH should be 
generated. The modification of the GC conditions did not alter the outcome. Therefore the 
peak exhibiting the same retention time as EtOH was considered as being an artefact of 
the enzyme mixture used producing either EtOH or a volatile compound with similar 
retention time during the incubation. 
Similar incubation experiments were then carried out with a different b-glucuronidase-
preparation. Glucurase, a bovine enzyme, was used. In contrary to glusulase no peaks 
were found at 4.2 min in any of the incubated samples. 
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It is possible that the glucuronide-bond of EtG cannot be hydrolysed with glucurase. Thus, 
the indirect analysis of EtG was not feasible using commercially available hydrolytic 
enzymes and other techniques with direct determination of EtG were looked at. 
 
LC-MS of ethyl-glucuronide 
An advantage of the LC-MS analysis of EtG is that no pre-column derivatisation is needed 
and that the lack of EtG’s uv-absorption may be circumvented with the mass-selective 
detector. A further advantage is that an optimal internal standard is commercially 
available in form of deuterated EtG (d5-EtG)5. The available ion-trap mass-spectrometer 
has the potential to produce spectra up to MS10 for the qualitative identification of 
metabolites. For this purpose, however, the concentrations of the fragments to be further 
fragmented need to be fairly high. Since our main-focus was to quantify EtG in serum and 
urine samples we would have preferred a triple-quadrupole mass-spectrometer as is it has 
been described in the literature53,119,136,147. Since no such triple-quadrupole LC-MS system 
could be used we nonetheless explored HPLC in connection with the ion-trap MS system. 
 
Method 
The equipment used for the analysis were a HP 1100 HPLC System with a G1322A 
Degaser, a G1311A QuatPump, a G1329A ALS and a G1316A ColComp for the separation 
and a Finnigan LCQ Ion Trap Mass-Spectrometer with electrospray-ionisation (ESI) for the 
detection of the compounds (spray voltage [kV]: 3.85; spray current [µA]: 2.15; sheath 
gas flow rate [psi]: 60; aux gas flow rate [psi]: 0; capillary voltage [V]: -4; capillary temp 
[°C]: 200). More details regarding ion optics and vacuum pump settings may be found in 
table 2. The column that was used for the separation of the compounds was a MN ET 250 
Nucleosil® 5 C18 column. 
 
For method development aqueous solutions of EtG and d5-ethyl-glucuronide (d5-EtG; 
Medichem Inc. Stuttgart, D) in different concentrations were used (1.56 – 250 µM). 
Substances were eluted with aqueous ammonia 0.025% (pH 8.0) and acetonitrile (8:2) at 
a flow rate of 0.2 or 0.3 mL/min. The run time was 10 minutes. According to the 
literature35,53,89,119,145 EtG was measured in negative mode (M-1).  
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Table 2: LCQ Settings for Analysis of EtG 
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Results 
In figures 6 and 7 the LC-MS chromatograms of EtG and d5-EtG aqueous standard 
solutions at a concentration of 250 µM (5 nmol o.c.) are shown. The upper part of the 
figure represents the corresponding mass-trace of EtG or d5-EtG respectively, while in the 
lower part of the figure the distribution of masses under the peak is shown; this data 
includes all masses between 60 and 400 atomic mass units (amu) that were detected by 
the ion-trap in the total ion current of either EtG or d5-EtG. 
The mass traced in the upper part of figure 6 is the molecular ion of EtG (molecular 
weight 222) in the negative mode (M-1) with a m/z ratio of 221. The isolation width for 
this m/z 221 was set to ± 1 amu (m/z 220 – 222). As expected the m/z 221 at its peak 
maximum was almost the only mass detectable in the total ion current. There was always 
a background signal present since, besides of the ions produced from our analytes, there 
was also a constant flow of solvents which already had passed a separation column and 
there were also some inevitable impurities within the system, which summed up to the 
total ion current. 
The masses that were present at 6.21 min out of the total ion current are shown in the 
lower part of figure 6. To begin with m/z 221 was the most prominent mass as expected. 
All masses smaller than 221 could be fragments that were created spontaneously during 
the analysis or must be considered as background noise from the system. Glucuronic acid 
without the ethyl group (molecular weight 194 ® m/z 193) was not detectable. The peak 
with m/z 173 could be a fragment ion of EtG after the loss of the ethanoyl group and a 
consequent rearrangement of the molecule including formation of double bonds. The 
quite prominent peak with m/z 395 is compatible with an adduct of a second glucuronic 
acid residue to EtG. 
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Fig. 6: LC-MS chromatogram of EtG standard 250 µM recorded with a flow-rate of 0.2 mL/min. The mass 
trace of m/z 221 is shown above and the mass distribution of the total ion current at the peak maximum 
(6.21 min) is shown below. 
 
In figure 7 the chromatograms for d5-EtG are shown. Since in the ethyl-group all of the 
hydrogen atoms have been replaced with deuterium atoms the molecular weight of d5-EtG 
is increased by 5 amu compared to EtG. Therefore the molecular weight is 227 amu and 
the corresponding negatively charged molecular ion had a m/z of 226. Here again the 
isolation width was set to ± 1 amu. The retention time of the deuterated form of EtG 
does not differ from that of ordinary EtG because the chemical and physical properties of 
both substances are identical except for the mass-difference. Regarding the mass-
spectrum in the lower part of figure 7 from the total ion current there are mainly the 
same ions present as it has been observed for EtG. Only two mass peaks present have 
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different masses. The expected molecular peak at m/z 226 and the proposed adduct of a 
second glucuronic acid residue which by now has a m/z of 400. The finding of this latter 
mass-peak which is indeed similar to the one found in the case of EtG (m/z 395) does 
support the explanation given for its nature. Also the origin of the m/z 173 peak remains 
plausible since with the ethanoyl group removed the deuterated part of the molecule has 
been cleaved away and the remaining fragment should undergo the same rearrangements 
under identical conditions as undeuterated EtG. 
 
 
Fig. 7: LC-MS chromatogram of d5-EtG standard 250 µM recorded with a flow-rate of 0.2 mL/min. The mass 
trace of m/z 226 is shown above and the mass distribution of the total ion current at the peak maximum 
(6.21 min) is shown below. 
 
For the quantification of EtG the internal standard d5-EtG was chromatographed together 
with EtG and the ratio of their peak areas was calculated. Sample chromatograms for EtG 
in concentrations from 1.56 µM to 250 µM (15.6 to 2500 pmol o.c.), each with 50 µM of 
d5-EtG (500 pmol o.c.) are shown below (figure 8). 
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Fig. 8: Comparison of three concentrations of EtG chromatographed with 50 µM of d5-EtG. The traces on the 
left side are those of EtG (m/z 221) in concentration (from above) 1.56 µM, 50 µM and 250 µM, the traces on 
the right are from the internal standard d5-EtG (m/z 226) in a concentration of always 50 µM. (flow rate 0.3 
mL/min) 
 
The quantification of EtG as the ratio of m/z 221 and m/z 226 provided a linear 
correlation between 0.4 and 250 µM (figure 9). A similar range for the linear 
quantification of EtG was reported by Nishikawa et al89. 
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Fig. 9: Plot of the ratio of m/z 221/226 against the concentration of EtG [µM] 
 
In a biological matrix like serum or urine other co-eluting ions with identical m/z-ratios as 
EtG (221) or d5-EtG (226) must be expected. To ascertain that the ions with m/z-ratios of 
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221 and 226 are really EtG or d5-EtG, respectively, we wanted to quantify their specific 
fragments. 
 
In principle there are two different ways of producing fragments. Either one specifies 
which mass should be fragmented and obtains the mass-spectrum of these fragments 
(MS2) or both, the mass to be isolated and fragmented and the resulting fragment one is 
interested in (single reaction monitoring, SRM), can be specified. The MS2 technique 
allows the monitoring of all fragments generated from the peak of interest so that the 
relative abundances of the single fragments may be taken into account when judging the 
origin of a fragment peak. The SRM technique allows a more sensitive monitoring of 
highly specific fragments that may appear in small quantities only. Since they are readily 
isolated out of the bulk of the other fragments they might be more significant for the 
quantification of the fragments. The fragmentation pattern in any case is strongly 
influenced by the amount of energy applied on the selected ions. A good setting for this 
purpose would leave part of the molecular ion unaffected and therefore still visible when 
MS2 spectra are recorded. 
Our ion-trap system requires a defined method (scan-event) for every ion that has to be 
fragmented. This way, for the complete analysis of one sample of EtG with internal 
standard three scan events need to be specified: one for the full scan mode where 
information about the (parent) ions m/z 221 and m/z 226 is collected and one each for 
the fragmentation of EtG and d5-EtG respectively. 
The ion-trap mass-analyser works on a discontinuous mode of action. Ions are collected 
by the trap for some time (dependent on the settings, but usually up to 200 ms) and then 
the inlet is closed until the desired scan event (full scan, MSn (n = 2–10), single ion 
monitoring (SIM), selected reaction monitoring (SRM), consecutive reaction monitoring 
(CRM)) has been carried out and is finished (takes about 200 µs). After that the ion-trap 
is refilled again and the next scan-event is carried out. If more than one scan event is 
selected, these are run consecutively resulting in gaps in the data-collection for the single 
scan-event. In our setting one turn of three scan events lasted about 2.4 seconds (0.8 
sec/scan-event). 
 
Based on an article of Wurst and co-workers146 the transition from m/z 221 to m/z 75 in a 
SRM method seems to be typical for EtG. Others have adapted this method for the 
identification of EtG53,119,136,145,147,148. 
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The MS2 fragmentation pattern of EtG is shown in figure 10. The parent ion (m/z 221) is 
still present in this setting (with 25 “energy units” used for the fragmentation). The 
resulting m/z 203 may derive from the loss of water and m/z 159 from a subsequent loss 
of carbon-dioxide. This m/z 159 may further lose an ethyl group (m/z 129) or an ethanoyl 
group (m/z 113). A loss of water from m/z 113 would result in a fragment with m/z 95, 
whereas a loss of carbon monoxide would leave a fragment with m/z 85. 
The fragment of interest (m/z 75) is the product of a different fragmentation cascade and 
is supposed to have either of the structures shown in figure 11. Of course there might be 
other possible structures, but these two are the most probable ones. 
 
 
Fig. 10: MS2 spectrum of EtG; the main fragments are addressed in the text (see above). The concentration 
of EtG was 125 µM (1.25 nmol o.c.) 
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Fig. 11: possible structures for the m/z 75 fragment from EtG (or d5-EtG) with their origin highlighted in the 
structure of the parent ion. 
 
The fragmentation pattern of d5-EtG is very similar to that of EtG (figure 12). As long as 
the deuterated ethanoyl group is present in the molecule the corresponding peaks have a 
m/z-ratio that is 5 amu higher than in EtG (m/z 226, m/z 208, m/z 164). After its removal 
the m/z ratios are the same (m/z 129, m/z 113, m/z 95, m/z 85, m/z 75) as in EtG. 
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Fig. 12: MS2 spectrum of d5-EtG; the main fragments are addressed in the text (see above). The 
concentration of d5-EtG was 125 µM (1.25 nmol o.c.) 
 
These fragmentation patterns were similar to those others had found earlier53,136. 
 
We planned to establish an automatic integration method for the recorded fragment 
peaks of the m/z 75 fragments of m/z 221 and m/z 226 for the quantification of EtG by 
the software of the MS. When recording MS2 chromatograms for the potential 
quantification of m/z 75 fragments reasonably shaped peaks were produced (figure 13). 
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Fig. 13: traces of m/z 221 and the corresponding m/z 75; of m/z 226 and its corresponding m/z 75. The m/z 
221 and 226 traces are isolated from the TIC whereas the m/z 75 were recorded in MS2 mode as separate 
scan events by isolation of m/z 221 or m/z 226 ions, respectively (flow rate 0.2 mL/min). The concentrations 
of EtG and d5-EtG were 125 µM (1.25 nmol o.c.) 
 
A similar situation as shown above for the MS2 fragmentation was found when a SRM 
fragmentation was applied (figure 14). After SRM the fragment peaks had less favourable 
shapes for automatic integration by the software of the MS, compared to the MS2-
method. This might be due to the discontinuous data collection by the MS when more 
than one scan event is carried out. 
Such fragment peaks of irregular shape and width may have peak areas that are not 
correlated to the amount of EtG in a direct linear mode. For the quantitative analysis of 
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EtG in urine or plasma samples peaks like those of the m/z 75 tracings in figure 14 are 
problematic for quantification. 
  
 
Fig. 14: traces of m/z 221 and the corresponding m/z 75; of m/z 226 and its corresponding m/z 75. The m/z 
75 fragments result of a SRM procedure isolating m/z 221 or m/z 226 ions, respectively, and recording the 
resulting fragments (flow rate 0.2 mL/min). The concentrations of EtG and d5-EtG were 125 µM (1.25 nmol 
o.c.) 
 
A series of diluted urine samples were analysed without any further sample pre-treatment 
prior to the analysis. The small amounts of EtG that must have been present in urine 
samples after the consumption of 1.2 L beer (one sample was collected 90 min. after the 
beer had been drunk, a second 5 h later and a third one after 12 h) could hardly be 
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detected by tracing the m/z 221 (EtG; figure 15). By tracing the m/z 75 fragment (after 
MS2) the presence of EtG could be confirmed. 
A different, shorter separation column was used for these chromatograms to avoid the 
contamination of the original column used in the other experiments (MN EC 125/2 
Nucleosil® 100-C18 HD instead of MN ET 250 Nucleosil® 5 C18). Therefore EtG was already 
eluted between 1.8 and 1.9 min as shown in figure 15.  
The following samples were analysed: an aqueous standard solution of EtG (50 µM), an 
urine blank and a sample of the urine 5 h after drinking 48 g of alcohol. The m/z 221 
tracing of EtG consists of a single peak at 1.86 min. and the MS2-spectrum provides the 
same fragments as seen before in figure 10. The m/z 221 tracing of the urine blank 
sample consists of many peaks and so does the one of the urine sample after drinking. To 
demonstrate the presence of EtG in the 5 h urine sample its m/z 75 tracing and the mass-
spectrum of m/z 221 after MS2 at 1.92 min. is shown at the bottom of figure 15. The EtG 
specific fragments with m/z 75, 113 and 203 are present in both of the spectra of EtG 
standard and the urine specimen after drinking indicating that EtG has been formed.  
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Fig. 15: the chromatograms (left) and MS2-spectra (right) of (from top) EtG 50 µM, urine blank and urine 5 h 
after consumption of 48 g of alcohol. The bottom line shows the m/z 75 tracing of the 5 h urine sample with 
the corresponding MS2-spectrum of m/z 221 at 1.92 min. 
 
To be able to judge the presence of EtG from the m/z 221 tracing already the urine 
samples need to be cleaned-up prior to analysis. To further improve the specific 
identification of EtG with the m/z 75 fragments and the MS2-spectra the samples should 
also be concentrated. Such chromatograms would then be comparable to results from 
previously published methods. 
 
Discussion 
A first difficulty of this LC-MS analysis was the fact that EtG does not absorb any light in 
the range of wavelengths suitable for analysis by HPLC and that we were therefore not 
able to optimise the HPLC system prior to the use of the MS so that we were confronted 
with the improvement of two systems at once. 
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One reason for the analytical difficulties may have been the generation of negatively 
charged ions from the HPLC-output for the analysis in the MS. The liquid phase that is 
present after the separation of the compounds on the HPLC system needs to be 
converted into a ionic gas-phase. This had been compared to the impossible union of a 
fish with a bird (figure 16). 
 
 
Fig. 16: the „impossible“ connection of HPLC and MS, like the union of a fish and a bird 
 
This problem has been largely solved nowadays. The electrospray-ionisation (ESI) that 
was used to produce the ions for the analysis in the MS allows the production of both 
positively and negatively charged ions depending on the settings of the polarity between 
the injection needle and the heat-capillary (figure 17). The entering liquid is dispersed at 
the edge of the needle into small droplets. These droplets need to lose the solvent and to 
be ionised. 
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Fig. 17: schematic drawing of the ESI ionisation (here with the polarity set for positive ions). 
 
There are two proposed models for the production of ions in Electrospray Ionisation: The 
Ion Evaporation Model (IEM) proposes the droplets to shrink due to the solvent 
evaporation, charges to move towards the surface of the droplet and the resulting charge 
density on the surface of the droplet to force ions out of it (figure 18). 
 
 
Fig. 18: schematic drawing of the Ion Evaporation Model for the generation of ions in electrospray-ionisation 
 
The Charged Residue Model (CRM) proposes the droplets to shrink and then break up due 
to coulombic forces creating micro-droplets containing one analyte ion only that – by 
further drying – will set free a completely desolvated ion (figure 19) 
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Fig. 19: schematic drawing of the Charged Residue Model (CRM) for the generation of ions in electrospray-
ionisation 
 
In ESI the building of positive ions is preferred over the negative ones. The ions in 
negative mode are supposed to present structures like [M-H]-, which might be thought of 
as a loss of “counter-cations” (Na+, K+, H+). The negative ions have a greater tendency of 
getting discharged88. ESI is the preferred method for (LC-) MS of macromolecules like 
proteins because near to no destruction and fragmentation of the ions is observed. The 
EtG in contrast to proteins is very small and it might therefore be more difficult to ionise 
these tiny particles. 
In order to improve the formation of the ions, the spray performance and the setting of 
the ion-optics the system was re-tuned several times. Only little improvement could be 
achieved this away. 
 
A further reason for these analytical difficulties might be the method of MS analysis. The 
ion-trap system is probably a sub-optimal choice for this kind of analysis. It is likely that a 
triple-quadrupole MS – that was described in the literature – would have performed 
better. 
 
If only the molecular ions (i.e. m/z 221 and m/z 226) were taken into account the method 
was comparable to other methods published. Our limit of detection (LOD), defined as a 
signal to noise ratio of 3, was about 200 µg/L (1 µM; 10 pmol o.c.; cf. figure 8) and the 
limit of quantification (LOQ; signal to noise ratio 10) 600 µg/L (~ 3 µM; 30 pmol o.c.). 
Janda et al reported a LOD (with a GC-MS) of 37 µg/L (~ 5 pmol o.c.) in serum and 168 
µg/L in urine52, whereas Schmitt et al reported a LOD of 100 µg/L in both serum and 
urine106. The previously published cut-off for considered abuse of alcohol – 5 mg/L in 
serum105,107 – would probably be detectable with our method; further analyses in urine (or 
serum) samples instead of the used aqueous standard solutions would have to prove this 
assumption. 
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GC of ethyl-glucuronide 
A different method to quantify EtG was necessary to investigate its metabolism in blood, 
urine and stool. Since the LC(-MS) approach was not as successful as expected a GC 
method was explored. EtG itself is a non volatile substance. A precolumn derivatisation 
was therefore needed. An overview of some of the possible procedures is depicted in 
figure 20. 
 
 
Fig. 20: overview of possible derivatives of EtG for GC analysis 
 
Acetylation of ethyl-glucuronide106,107 
Method 
The acetylation of EtG with acetic acid anhydride as it has been described in the 
literature106 was thought to be a good method for the analysis of EtG. 
100 µL of an aqueous solution of EtG in concentrations ranging from 125 to 1000 µM 
were dried under a stream of air in a 10 mL Sovirel®-vial. 300 µL of acetic acid anhydride 
were added and the solution was incubated at 80°C for 30 min. on a heat-block (intern. 
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Laborat. App. GmbH, D- Dottingen; M22/1). The solution was air-dried again, the residue 
dissolved in 100 µL of methanol and one µL thereof was injected for analysis by a HP 
5890 series II gas chromatograph with flame ionisation detection (FID). A MN Optima 1 
10 m x 0.2 mm; 0.35 µm GC-column was used for the separation of the compounds. Gas 
flows were as follows: nitrogen carrier gas 207 kPa, air 283 kPa and hydrogen 124 kPa. 
The total gas-flow was between 90 and 100 mL/min. The oven temperature was kept at 
170°C (isotherm), the injector was set at 200°C and the detector at 240°C. 
 
Results of the acetylation 
In figure 21 the chromatogram of a reagent blank is compared to the chromatogram of a 
250 µM aqueous solution of EtG. The blank was prepared by drying 100 µL of water 
instead of an aliquot of dissolved EtG. The peak corresponding to the acetylated form of 
EtG (EtGOAc) is detected after 3.5 min. The peak corresponding to the acetylated form of 
EtG could also be detected in an urine sample spiked with EtG prior to derivatisation 
(figure 22). 
 
 
Fig. 21: GC chromatogram a) of a blank showing no peak at 3.5 min and b) of acetylated EtG in a 
concentration of 1 mM with its peak at 3.5 min. 
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In figure 22 the chromatogram of an urine blank is compared to an urine sample spiked 
with EtG. For the blank 100 µL of urine from a teetotaller were dried and derivatised 
afterwards as described above. The spiked sample was prepared by adding 50 µL of a 
500 µM aqueous EtG solution to 100 µL of an other aliquot of the same urine and 
evaporating the mixture to dryness before derivatisation. 
 
 
Fig. 22: a) acetylated urine sample without EtG; b) the same urine sample spiked with 500 µM EtG. EtG peak 
at 3.5 min. 
 
The EtGOAc-peak appeared in a section of the chromatogram where no other disturbing 
peaks were present in the blank urine.  
 
The lowest concentrations we were able to detect with this derivatisation method were 
more than 20 times higher than the concentrations we expected to be present in urine or 
plasma. Because of these facts and bearing in mind that other derivatisation procedures 
might provide better results the further evaluation of the method was ceased. 
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Halogenation of ethyl-glucuronide121 
Method 
To improve the GC sensitivity of the derivatised EtG we chose halogenation for the 
derivatisation and electron-capture detection (ECD) for the detection of the resulting 
products. Compounds containing halogens like chlorine or fluor should be detected with a 
far higher sensitivity by ECD than by the rather unspecific flame-ionisation detection 
(FID). 
100 µL of a methanolic solution of EtG in concentrations from 1.56 µM to 400 µM were 
dried under a stream of air. 250 µL of ethyl acetate (EtOAc) and 25 µL of halogenation 
reagent (trifluoroacetic acid anhydride (TFAA) or pentafluoropropionic acid anhydride 
(PFAA); Fluka, Buchs CH) were added and the solution incubated at 60°C for 30 min. The 
solution was air-dried and the residue redissolved in 50 µL of EtOAc. One µL thereof was 
injected for analysis by a HP 5890 series II gas chromatograph with electron capture 
detection (ECD). A MN Optima 17 25 m x 0.25 m; 0.25 µm GC column was used. The 
total gas-flow was set to 57 mL/min.  For the analysis of TFA-esters of EtG the oven was 
set at 100°C, the injector at 180° and the detector at 250°C. For the analysis of PFA-
esters of EtG the oven was set at 120°C, the injector at 200°C and the detector at 250°C. 
 
Results of the halogenation 
The products after derivatisation with TFAA did not provide peaks that could be assigned 
to EtG derivatives with certainty. Since no such derivatives could be found by using TFAA 
the higher fluoridated PFAA was explored (figure 23). These PFA-esters yielded peaks for 
the EtG derivatives but the reproducibility of this derivatisation was far from being 
satisfying. We observed that peak areas of one single concentration of EtG after 
derivatisation with PFAA differed by more than a factor 10, indicating strongly that these 
derivatives were unstable. Therefore the reproducibility of this approach was not 
sufficiently reliable although with this halogenation method we were able to detect EtG 
derivatives at lower concentrations than with the acetylation procedure described above. 
Nonetheless the non-linearity of the concentration to signal ratio as well as the poor 
reproducibility of this method did not allow us to base all of the further planned 
experiments on this method. 
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Fig. 23: Chromatograms of EtG pentafluoro-propionic acid anhydride (PFAA) derivatives; the EtG-PFA-ester 
peak has a retention time of about 5.2 min. a) only the solvent EtOAc, b) 1.56 µM EtG-PFA, c) 25 µM EtG-PFA, 
d) 400 µM EtG-PFA 
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Silylation of ethyl-glucuronide 
One last approach to the analysis of EtG by GC or GC-MS was the silylation of the 
hydroxyl-groups as a simple and effective derivatisation procedure52,146. The EtG contains 
four hydroxyl-groups in the glucuronic acid residue which may all be silylated. Thus highly 
volatile derivatives should be produced and a good sensitivity for their analysis can be 
presumed.  
 
Method 
100 µL of an aqueous solution of EtG in concentrations ranging from 125 to 1000 µM 
were dried under a stream of air in a 10 mL Sovirel®-vial. 40 µL of acetonitrile and 10 µL 
of N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) were added, and the 
solution was incubated at 80°C for 30 min. on a heat-block (intern. Laborat. App. GmbH, 
7801 Dottingen; M22/1). One µL thereof was injected for analysis by a HP 5890 series II 
gas chromatograph with flame ionisation detection (FID). A MN Optima 1 10 m x 0.2 mm; 
0.35 µm GC-column was used for the separation of the compounds. Gas flows were as 
follows: nitrogen carrier gas 207 kPa, air 283 kPa and hydrogen 124 kPa. Total gas-flow 
was between 90 and 100 mL/min. For the analysis of these tert-butyldimethylsilyl 
(TBDMS)-derivatives the oven temperature was set at 110°C, the injector at 200°C and 
the detector at 240°C. 
For the GC-MS we used a HP 5890 series II gas chromatograph connected to a HP 5871 
mass-spectrometer operated in electron impact mode (Hewlett-Packard, Palo Alto, CA). 
Gas chromatographic separation was accomplished on a MN Optima 1 12 m x 0.2 mm; 
0.35 µm GC-column. The injector temperature was set at 260°C and the detector at 
300°C. Helium was used as the carrier gas with a total flow of 0.9 mL/min. For the GC 
separation of the compounds the oven temperature was increased after two minutes at 
110°C at a rate of  25°C/min to 250°C where it was kept constant for 3 minutes. 
 
Results of the silylation 
The derivatisation products of EtG with MTBSTFA (EtG-TBDMS) were found with good 
reproducibility at 4.6 min. with the GC-FID method. Since the derivatives proved to be 
quite unstable against any humidity we started looking for a suitable internal standard. 
Out of the substances tried out for this purpose none could be used because either its 
TBDMS-derivative got lost in the solvent front or co-eluted with EtG-TBDMS. 
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A sample chromatogram of EtG-TBDMS in a concentration of 250 µM (0.5 nmol o.c.) is 
shown in figure 24. 
 
 
Fig. 24: chromatogram of EtG-TBDMS in a concentration of 250 µM, with the corresponding peak at 4.6 min. 
 
Even tough the chromatograms looked promising we were experiencing problems with 
the peak of interest at 4.6 min. Probably caused by the instability of the silylated products 
series of identical concentrations of EtG derivatives produced peak areas in the 
chromatograms that differed by up to a factor 5. Even blank chromatograms where the 
EtG solution had been replaced by pure water produced (small) peaks at 4.6 min. 
 
Due to the size of EtG-TBDMS derivatisation of EtG with BSTFA would likely provide 
derivatives that are better suited for GC-MS. Aqueous standard solutions resulted in well 
detectable peaks and the mass difference of EtG and d5-EtG was seen in some of the 
fragments (difference of 5 amu). Figure 25 shows a GC-MS chromatogram with the 
corresponding mass spectrum of EtG in scan-mode whereas figure 26 shows the 
respective d5-EtG chromatogram and spectrum. In these spectra the same fragments 
were found as was reported in the literature5,100. 
 
Metabolites of ethanol as markers of alcohol abuse / Glutathione consumption and methionine kinetics in humans 
 
 
Andreas Schmid Inauguraldissertation, University of Basel Page 54 
 
Fig. 25: Chromatogram of silylated EtG and the corresponding mass-spectrum at the peak-maximum 
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Fig. 26: Chromatogram of silylated d5-EtG and the corresponding mass-spectrum at the peak-maximum 
 
Alt and coworkers5 used the fragments with m/z 160, 261 and 405 for the identification of 
EtG and the m/z pair 405 and 410 for the quantification of EtG. 
 
One explanation how the fragment with m/z 405 (for EtG) or 410 (d5-EtG) can be 
generated is the loss of a trimethylsilyl group including the adjacent oxygen atom plus a 
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single methyl group. The further loss of the carbonyl group (with the TMS group) and part 
of the ring structure leads to one of many possible m/z 261 (m/z 266) fragments. After 
the loss of a further TMS group and an oxygen and a carbon atom a fragment with m/z 
160 (m/z 165) remains. The structures of such fragments are shown in figure 27. 
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Fig. 27: structure of the molecular ion after derivatisation with BSTFA and possible structures of the 
fragments monitored by Alt and coworkers5. Since the ethanoyl group is present in all those fragments 
depicted, the structures may also explain the corresponding fragments of d5-EtG. 
 
These three fragments are those that are different in EtG and d5-EtG. All the other main 
fragments have the same m/z ratios for EtG and d5-EtG indicating that the ethanoyl group 
is easily cleaved during fragmentation. 
In spite of several attempts to clean up and concentrate EtG the necessary sensitivity to 
quantitate EtG by GC-MS could not be achieved. 
 
Discussion of ethyl-glucuronide analysis 
The analysis of EtG has been described in several publications and it may be introduced in 
routine laboratory in the near future. The method of choice is probably a LC-MS method, 
because not only the peak might be found but it can also be identified with certainty. We 
have tried to adapt the existing methods for our needs to be able to investigate further a 
possible enterohepatic circulation of EtG and to find out whether there would be a source 
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of microbially generated EtOH metabolites. In addition this would have enabled us to also 
focus on the role of EtG in the toxicity of alcohol. 
 
To our great disappointment the adaptation of existing methods to our presently available 
laboratory equipment in a reproducible and sensitive fashion was much more time 
consuming than expected. Thus, the analysis of EtG, which would have been the basis for 
future research, could not be continued any further. 
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Ethyl-Lysine 
Ethyl-lysine (EtLys), one of the products of the reaction of acetaldehyde (AcHO) with 
amino groups, has been detected with antibodies directed against AcHO-modified proteins 
in tissue and plasma of subjects abusing alcohol17,68,85,86,132,140,143. The wide variety of 
different chemical forms of AcHO-adducts (AA; cf. introduction) which provoke many 
different antibodies70 proved to be a problem for the comparison of the results between 
laboratories. Furthermore the cross reactivity of the antibodies with structures similar to 
EtLys modified proteins could possibly provide false positive results. 
The elucidation of the different structures of these adducts has been of major interest. As 
an intermediate product the structure of a Schiff base was expected. Schiff bases present 
themselves as an equilibrium between an imine form (with a double bond between the 
carbon and the nitrogen atoms) and an enamine form (where the double bond is situated 
between two carbon atoms; figure 28) 
 
 
Fig. 28: The Schiff base is an equilibrium between a carbanion (imine) and an enamine 
 
The Schiff bases are not stable structures and it is not possible to isolate them but they 
may be stabilised by reduction. In in vitro experiments sodium-borohydride (NaBH4) or 
sodium-cyano borohydride (NaCNBH3) was used for this purpose. Tuma et al. have also 
employed ascorbic acid131,132; this could be one way how the reduction is effected also in 
vivo.  
From these data we concluded that in order to form stable EtLys a reduction step is 
needed to stabilize the putative Schiff bases formed between free amino groups and the 
carbonyl group of AcHO (figure 30). The proposed reaction scheme for the synthesis of e-
EtLys, as it would be formed in proteins, is shown below in figures 29 - 31. To ascertain 
the exclusive formation of e-EtLys a-tert-butyloxycarbonyl (BOC)-Lys was used as starting 
reagent. The reduction of the Schiff base was achieved with NaCNBH3 and hydrolysis with 
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hydrochloric acid was used to remove the protecting a-BOC-group and thus liberating the 
synthesised e-EtLys. 
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Fig. 29: reaction of a-BOC-Lys with AcHO resulting in a Schiff base 
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Fig. 30: reduction of the Schiff base with sodium-cyanoborohydride 
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Fig. 31: acidic removal of the BOC protecting group resulting in e-EtLys 
 
To avoid the drawbacks of the immunologic approaches the aim of the present study was 
therefore to explore the possibility of analysing and quantifying EtLys in circulating 
proteins by chromatographic means. EtLys in circulating albumin which has a half-life of 
14-20 days in man, but only approximately 2-3 days in rats33,36,57,94, could provide a 
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marker for increased consumption of alcohol. Similar to glycosylated haemoglobin in 
patients with diabetes mellitus an ethylated form of haemoglobin has been proposed120 as 
a marker for alcohol abuse with a half-life of around 120 days. 
 
Our first aim was to develop a GC-MS method for the identification and quantification of 
EtLys in proteins. Based on our previous experience with the gaschromatographic-
massspectrometric analysis of amino acids99 the possibility of using a chromatographic 
analysis of silylated EtLys was first explored. Subsequently additional derivatisation 
procedures were investigated. 
 
GC (-MS) 
Method 
Silylation 
100 µL of an aqueous solution of EtLys (N6-ethyl-D,L-lysine hydrobromide; Toronto 
Research Chemicals, North York, Ontario, Canada) in concentrations from 50 to 500 µM 
were dried under a stream of air in Reacti-vials. 40 µL of acetonitrile and 10 µL of 
silylation reagent (BSTFA + 1% TMCS or MTBSTFA) were added and the tubes were 
incubated at 80°C for 30 min. After cooling one µL thereof was injected into the gas-
chromatograph. 
 
Halogenation 
100 µL of a methanolic solution of EtLys in concentrations from 125 to 500 µM were dried 
under a stream of air. 250 µL of ethyl acetate (EtOAc) and 25 µL of halogenation reagent 
(TFAA or PFAA) were added and the solution was incubated at 60°C for 30 min. The 
solution was air-dried and redissolved in 50 µL EtOAc. After cooling one µL thereof was 
injected into the gas-chromatograph. 
 
Chromatographic analysis 
In order to determine the optimal chromatographic conditions the derivatised EtLys was 
first analysed using a HP 5890 series II gas chromatograph with flame ionisation 
detection (FID). A MN Optima 1 10 m x 0.2 mm; 0.35 µm GC-column was used for the 
separation of the compounds. Gas flows were as follows: nitrogen carrier gas 207 kPa, air 
283 kPa and hydrogen 124 kPa. Total gas-flow was between 90 and 100 mL/min. The 
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column was heated according to the following program: 110°C for 2 min, then increment 
of the temperature at a rate of 15°C/min up to 250°C where the temperature was kept 
for 8 min. The temperature of the injector was set at 240°C and the temperature of the 
FID-detector at 270°C. 
 
For the analysis of tri- and penta-fluoro-acetylated EtLys the oven temperature started at 
70°C for 2 min. It then increased at a rate of 15°C/min. up to 250°C where it was kept 
for 4 min. The injector was set at 240°C and the ECD Detector at 280°C. 
 
The chromatographic conditions for GC-MS were as follows: a HP 5890 series II gas 
chromatograph connected to a HP 5971 mass spectrometer operated in the electron 
impact mode (Hewlett-Packard, Palo Alto, CA). Gas chromatographic separation was 
accomplished on a MN Optima 1 12 m x 0.2 mm, 0.35 µm GC-column. Injector 
temperature was set at 260°C and detector temperature was 300°C. Helium was used as 
the carrier gas with a total flow of 0.9 mL/min. The oven temperature increased from 
110°C (2 min) to 250°C (3 min) at a rate of 25°C/min. 
 
Results 
Figure 32 depicts a gas-chromatographic tracing of the BSTFA derivative of lysine (Lys) 
using FID. With GC-MS the silylated Lys and EtLys were detectable (figures 33 and 34). 
However, the concentrations required for an adequate, quantifiable signal were much 
higher than we expected them to be in plasma samples. 
 
Therefore a procedure to concentrate the samples was necessary because we aimed to 
detect EtLys in plasma, where a high background of amino acids and other compounds 
would complicate the analysis. In order to isolate and concentrate EtLys we used a 
SepPak extraction based on anion exchange chromatography prior to derivatisation, but 
the recovery of the compounds of interest was so low that the sensitivity of GC-MS was 
judged to be inadequate to analyse EtLys in protein hydrolysates. 
 
Metabolites of ethanol as markers of alcohol abuse / Glutathione consumption and methionine kinetics in humans 
 
 
Andreas Schmid Inauguraldissertation, University of Basel Page 62 
 
Fig. 32: BSTFA-derivative of Lys 500 µM; detection by GC-FID 
 
In order to potentially increase the sensitivity halogenation and subsequent detection by 
ECD was explored. No reaction product of Lys and EtLys with either TFAA or PFAA was 
found. 
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Fig. 33: GC-MS chromatogram of Lys 500 µM (derivatised with BSTFA + 1% TMCS, in acetonitrile) and the 
resulting fragments. Below possible structures of the major fragments. 
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Fig. 34: GC-MS chromatogram of EtLys 500 µM (derivatised with BSTFA + 1% TMCS, in acetonitrile) and the 
resulting fragments. Below possible structures of the major fragments. 
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LC-MS 
Analysis of EtLys using LC-MS was the method we explored next. The expected 
advantages were that no derivatisation was needed and that a high specificity would be 
achieved. 
 
Method 
For LC-MS analysis aqueous solutions of standards were directly used for method-
development. The equipment used for this analysis was a HP 1100 HPLC System with a 
G1322A Degaser, a G1311A QuatPump, a G1329A ALS and a G1316A ColComp. For the 
separation of the compounds a MN ET 250/4 Nucleosil® 100-5 SA column was used.  
Substances were eluted with aqueous sodium hydroxide 0,001% (pH 7,4) and acetonitrile 
(1:1) with a flow rate of 0.4 mL/min and a runtime of 10 min. Detection: Finnigan LCQ 
Ion Trap Mass-Spectrometer with electrospray-ionisation (ESI). Spray voltage [kV]: 3.54; 
spray current [µA]: 15.82; sheath gas flow rate [psi]: 60; aux gas flow rate [psi]: 0; 
capillary voltage [V]: 17.42; capillary temp [°C]: 250. More details regarding ion optics 
and vacuum pump may be found in table 3. 
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Table 3: LCQ Settings for Analysis of ethyl-lysine 
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Results 
EtLys has a molecular mass of 174.2 and a m/z ratio of 175.2 in the expected ionised 
state. Figure 35 shows the corresponding ion tracing of EtLys and figure 36 the 
fragmentation pattern of the peak at 4.55 min.  The m/z ratios of 175.2, 168.8 and 158.2 
are likely to represent the molecular ion, a possible loss of seven hydrogen atoms and a 
loss of an amino- or hydroxyl-group, respectively. The m/z ratios of 176.2 and 176.8 are 
suspected to result from the natural abundance of stable isotopes of C, H, N and O (13C, 
2H, 15N, (17O), 18O). 
 
 
Fig. 35: Mass trace of m/z 175.2, the aqueous standard solution of EtLys, from the total ion current 
 
 
Fig. 36: fragmentation pattern of EtLys at 4.55 min (cf. figure 35) 
 
When standard mixtures of amino acids were analysed using the described 
chromatographic method it turned out that arginine (Arg), another dibasic amino acid, 
had the same retention time. It also had the identical mass and fragmentation pattern 
(figures 37 and 38). 
 
Metabolites of ethanol as markers of alcohol abuse / Glutathione consumption and methionine kinetics in humans 
 
 
Andreas Schmid Inauguraldissertation, University of Basel Page 68 
 
Fig. 37: Mass trace of m/z 175.2, the aqueous standard solution of Arg, from the total ion current 
 
 
Fig. 38: fragmentation pattern of Arg at 4.57 min. (cf. figure 37) 
 
 
Fig. 39: MS2-mass-spectra of EtLys and Arg at 4.55 and 4.57 min. respectively (cf. figures 35 and 37). 
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The fragments of the MS2-spectra of the two amino acids were qualitatively similar, but 
the relative abundance of selected masses was different (figure 39). The molecular ions 
(175.2) are present. There is probably a NH2-group that is more easily removed in Arg 
than in EtLys resulting in a more abundant m/z 158.2 fragment (figure 40). The loss of 
the N-ethyl-group (including N) results in the leading fragment with m/z 130.1 from EtLys 
(figure 41). There is nonetheless also a fragment with m/z 158 in EtLys and a fragment 
with m/z 130 in Arg. Consequently, the percentage of EtLys cannot be calculated from the 
MS2-spectra of a mixture of Arg and EtLys (as it is present in plasma samples). 
 
 
Fig. 40: possible fragment with a m/z ratio of 158.2 from Arg 
 
 
Fig. 41: possible fragment with a m/z ratio of 130.1 from EtLys 
 
Attempts to separate the two amino acids by varying the conditions of the 
chromatographic analysis were unsuccessful due to the limited choice of solvents that can 
be used in LC/MS.  
 
HPLC 
To overcome the limitations of solvents from LC-MS, a HPLC method with uv detection 
was adapted to our needs. For this purpose amino acids had to be derivatised. We have 
applied a method with phenyl-isothiocyanate (PITC) to obtain compounds suitable for uv 
detection at 254 nm. 
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Method 
50 µL of a solution of amino acids were dried under a gentle stream of air at room 
temperature. The residue was dissolved in 10 µL of coupling buffer A (100 µL of methanol 
+ 100 µL of water + 50 µL of triethylamine), well mixed and air dried. The resulting 
residue was then dissolved in 10 µL of coupling buffer B (420 µL of methanol + 60 µL of 
water + 60 µL of triethylamine + 6 µL of PITC) mixed and incubated for 20 min. at room 
temperature. The solution was then dried on a SpeedVac (Maxi Dry Plus, Kleiner AG, 
Wohlen, CH) for 45 min at 35–40°C. The residue was dissolved in 100 µL of water and 10 
to 20 µL thereof were subsequently analysed by HPLC. 
 
A gradient system with potassium phosphate buffer 50 mM (pH 6.2) and acetonitrile was 
used to separate the PITC-amino acids. The solvent system of ammonium acetate and 
acetonitrile mentioned in the literature132 had to be abandoned due to incompatibilities 
with the HPLC-pumps.  
The following gradient was used (table 4):  Solvent A = potassium phosphate buffer 50 
mM (pH 6.2), solvent B = acetonitrile; flow rate: 0.5 mL/min. Detection at 254 nm. 
 
Table 4: HPLC gradient used for the separation of PITC derivatised amino acids 
Time [min.] % A % B 
  0.00 90 10 
25.00 70 30 
35.00 60 40 
40.00 60 40 
40.01 90 10 
 
Results 
A chromatogram of a standard solution of 15 amino acids is shown below (figure 42). The 
compounds of interest, namely Lys and EtLys, were clearly separated. Other dibasic 
amino acids, in particular Arg, did not interfere with the analysis. When the amino acids 
Lys and EtLys were injected in the same concentrations the ratio of their peak areas was 
in the range of 0.97–1.03 and they were detected with higher sensitivity than all the other 
amino acids at the same concentration (figure 43). We could measure EtLys down to 4 
µM (figure 44).  
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Fig. 42: A mixture of 15 amino acids, including alphabetically (3 letter code where applicable) Ala, Arg, 
ethionine, EtLys, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Thr and Val, all in a concentration of 500 µM (5 
nmol o.c.). This mixture was used as a reference for peak identification and the system’s performance and 
stability. 
 
 
Fig. 43: the mixture from figure 42, but the concentration of the amino acids was only 15 µM (156 pmol o.c.) 
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Fig. 44: calibration curve of EtLys by HPLC 
 
Analysis of Ethyl-Lysine in proteins 
Method 
Blood sample preparation 
In order to detect EtLys in circulating proteins 100 µL of plasma, serum or erythrocytes 
were mixed with 100 µL of phosphate buffer 0.1 M (pH 7.4) and 200 µL of sodium-cyano 
borohydride 1 mM (in H2O) and incubated for one hour at room temperature for the 
reduction of unstable AcHO adducts i.e. Schiff bases. The proteins were precipitated by 
addition of 100 µL of ice-cold 15% sulfosalicylic acid. After centrifugation the supernatant 
was discarded. The residue was then hydrolysed for two hours at 150°C after the addition 
of 1000 µL of 6 M hydrochloric acid. This procedure hydrolyses proteins to its constituent 
amino acids98. 
 
After cooling the mixture to room temperature it was dried under a gentle stream of air at 
40°C. The residue was dissolved in 1000 µL of water, mixed well and centrifuged in an 
Eppendorf Centrifuge 5415 C at 14000 rpm for 5 minutes. 50 µL of the supernatant were 
derivatised for amino acid analysis as described above.  
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Generation of ethyl-lysine in proteins  
Human albumin (4, 6 and 40 mg/mL) was incubated with AcHO (10 µM up to 5 mM) for 
up to 10 days at 37°C. Identical incubations were done with a-BOC-Lys (0.2, 4 and 6 
mg/mL) instead of albumin. After incubation the a-BOC-group can be removed by acidic 
hydrolysis releasing e-EtLys and unreacted Lys. 
In order to find the optimal incubation time 475 µL of a-BOC-Lys (4 mg/mL) or albumin 
(40 mg/mL) were mixed with 475 µL of 2 mM AcHO and 50 µL of water or 50 µL of 10 
mM NaCNBH3. 
 
In order to find out whether rising concentrations of AcHO would result in a linear rise of 
EtLys, 475 µL of albumin (40 mg/mL) were incubated with 475 µL of AcHO 0, 10, 20, 50, 
100, 200, 500 µM or 1, 2, 5 mM. Again, 50 µL of 10 µM NaCNBH3 was added. 
 
Results 
Generation of ethyl-lysine in the presence of acetaldehyde 
Albumin and a-BOC-Lys were incubated over a period of 10 days with AcHO at a final 
concentration of 1 mM (figures 45 - 47). Half of the samples were incubated with 
NaCNBH3 under reducing conditions, and half of the samples were incubated without 
reducing agent but were reduced with NaCNBH3 after the incubation with AcHO for 1 h at 
room-temperature. Aliquots were withdrawn every second day to determine the ratio of 
EtLys to Lys and thus the optimal incubation time.  
 
Samples that were not reduced during the incubation did not yield any stable EtLys, even 
after reduction for 1 h at the end of the incubation period. Samples incubated in the 
presence of NaCNBH3 that were further reduced after the incubation did not show a 
further increase in EtLys formation. 
 
When incubating a-BOC-Lys there was no plateau yet after 10 days. Incubation of 
albumin did not yield the same amounts of EtLys. This might be due to the fact, that a-
BOC-Lys was free in solution, whereas the Lys residues of albumin are bound in the 
protein and therefore less accessible to AcHO (steric hindrance).  
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Fig. 45: Sample chromatogram of hydrolysed and reduced albumin blank 
 
 
Fig. 46: Albumin after incubation with 1 mM AcHO (under reducing conditions) for 10 days and subsequent  
hydrolysis and derivatisation. 
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Fig. 47: Generation of EtLys from a-BOC-Lys and albumin when incubated with 1 mM AcHO. Alb red = 
albumin, reduced during incubation time only; Alb red + = albumin, reduced during incubation and after 
incubation; Lys red = a-BOC-Lys, reduced during incubation time only; Lys red + = a-BOC-Lys, reduced 
during incubation and after incubation. 
 
In a second series of experiments the incubation time was kept constant and the 
concentration of AcHO was varied from 10 µM to 5 mM. The lowest AcHO concentrations 
did not result in any measurable EtLys and the ratio of EtLys and Lys was, therefore, not 
different from the blank (where no AcHO was added). Concentrations greater than 50 µM 
resulted in a concentration-dependent increase in the EtLys:Lys ratio up to a 
concentration of AcHO of 5 mM (figure 48).  
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Fig. 48: Generation of EtLys from albumin incubated with different concentrations of AcHO. Samples were 
incubated for 6 or 10 days. 
 
The amount of Lys that was ethylated by AcHO yielding EtLys was only a few percents as 
it is reflected by their ratio. 
Plasma AcHO levels in vivo (Caucasians) only reach levels of about 50 µM38,120. After the 
consumption of 1 g of alcohol per kg of body weight within two hours AcHO levels were 
still below detection limit, whereas an oriental subject who consumed only 0.1 g/kg of 
alcohol had AcHO levels of 15 µM84. The intracellular AcHO concentration is likely to be 
higher because that is the compartment where the metabolism of EtOH takes place. Most 
of the generated AcHO is readily further metabolised to acetate by the aldehyde-
dehydrogenase. Since AcHO is a highly reactive molecule it will react with intracellular 
structures like proteins and DNA. All proteins that are synthesised in alcohol metabolising 
cells – mainly hepatocytes – may be a target of free AcHO thus preventing it to reach the 
plasma. 
  
Ethyl-lysine in ethanol-fed rats 
Animals 
Male alcohol naïve rats (Wistar) of about 200 g body weight at start were used. After an 
initial blood sample had been obtained from the retro orbital plexus in slight anaesthesia 
as base line, the animals were fed an alcohol diet (see table 5 for details) for 4 weeks. 
After 4 weeks on the alcohol diet the rats were maintained on a regular, alcohol-free diet. 
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Further blood samples were taken every week for 6 weeks to determine the 
concentrations of blood alcohol and plasma EtLys. The protocol was approved by the local 
animal welfare committee.  
 
Table 5: composition of the alcohol-containing liquid diet for rats 
Resource Meritene®  87 g 
Thistle oil 5 g 
Plain milk 400 ml 
Supradyn® effervescent 4.7 g 
Ethanol 63.3 ml 
 
Determination of Blood Alcohol Concentration 
Blood alcohol concentrations of the rats were measured after the third week on the 
alcohol diet. 
A photometric assay, based on the measurement of NADH, which had been modified from 
a method for an automated analysis, was used. 320 µL of water was mixed with 500 µL of 
buffer pH 9.0 (300 mM 1,3-diamino-2-propanol (Sigma-Aldrich, St. Louis MO, USA) 
adjusted with hydrochloric acid) and 10 µL of sample were added. The reaction was 
started by addition of 150 µL of a mixture of 36 mM NAD (free acid, crystallized; 
Boehringer Mannheim GmbH, D) and 2000 µcat/L ADH (from yeast, lyophilised; 
Boehringer Mannheim GmbH, D) in 50 mM sodium citrate buffer. The reaction was 
followed on the spectrophotometer by measuring the samples every 10 seconds for 5 
min. at 378 nm. Noise at 409 nm was subtracted for better performance. 
 
Results 
Each rat consumed approximately 1.85 g of ethanol per 100 g body-weight per day 
(figure 49). One of the five rats died after one week on the alcohol diet. During the 
experiment the animals put on weight after a slight decrease at the beginning of the 
alcohol feeding period (figure 50). The four rats had blood alcohol levels in a range of 3.5 
up to 30.0 mM in the early morning (figure 51). The large interindividual difference is 
most likely due to the fact that they were consuming their diet at different time points 
during the night. Since they all gained weight during the preceding three weeks the 
animals most likely consumed approximately the same quantity of alcohol. Concentrations 
of around 14 mM are found in humans 30 minutes after consumption of 0.5 g ethanol per 
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kg body weight. At baseline and also after six weeks no EtLys was found in any sample. 
Already after one week EtLys was detectable in circulating proteins. The ratio remained 
elevated for two more weeks, before it started to drop during the last week of the alcohol 
diet. Upon removal of EtOH from the diet the EtLys disappeared within two weeks (figure 
52). 
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Fig. 49: Mean daily alcohol consumption per animal plotted as grams of ethanol per 100 g of body weight. 
This was calculated from the amount of food prepared and from what remained the following day. 
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Fig. 50: Weight development of the animals during the alcohol diet period; animal no 4 died after the first 
week on the diet 
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Fig. 51: Concentration of ethanol [mM] in rat plasma early in the morning (after 3rd week on alcohol diet) 
and the calibration curve for the measurement of ethanol. 
 
 
Fig. 52: plot of the ratio of EtLys to Lys in the plasma proteins of rats, shown as box plots with median and 
range, n=5 for the weeks 0 and 1, n=4 for the rest of the study period. 
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Ethyl-lysine in Humans 
Method 
Blood samples from 6 patients, known as alcoholics and under treatment for alcoholic 
liver disease, were received from our hepatological outpatient clinic. The patients were 
asked during a follow-up visit to donate an additional blood sample (besides the samples 
needed for the check-up) for the purpose of this analysis. From all patients heparinised 
blood samples were obtained. These were centrifuged immediately and plasma was 
removed. The volume of plasma removed was substituted with sterile isotonic sodium 
chloride solution 0.9%. After mixing this “recombinant blood” was used to test for EtLys in 
erythrocytes following the procedure described above. 
As a control blood samples of one subject were analysed after a three week period during 
which an average of 50 g of alcohol was consumed daily and after a washout period of 
one month during which no alcohol at all was imbibed. 
EtLys was determined in plasma proteins (after their hydrolysis) and in erythrocytes after 
their haemolysis and precipitation of erythrocyte proteins with sulfosalicylic acid as 
described for plasma proteins. 
 
Results 
There exists in fact a relation between alcohol consumption and the presence of EtLys in 
the plasma proteins of humans as it was seen in our control subject. After the three week 
drinking period of an average of 50 g of pure EtOH daily (in form of beer or wine) a well 
detectable EtLys peak was found in the plasma proteins as shown in figure 53. To make 
sure the suspected peak was EtLys indeed, the sample was spiked with 50 µM of EtLys 
and reanalysed (figure 54). 
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ratio EtLys/Lys 0,004 
Fig. 53: Chromatogram of a control subject after 3 weeks of a daily consumption of 50 g of alcohol on 
average. 
 
 
ratio EtLys/Lys 0,021 
Fig. 54: The sample from figure 53 spiked with 50 µM EtLys 
 
After the washout period during which the subject did not consume any alcohol at all an 
other blood sample was analysed. The amount of EtLys was hardly detectable (figure 55) 
and again this finding was secured by spiking the sample with EtLys (figure 56).  
 
Metabolites of ethanol as markers of alcohol abuse / Glutathione consumption and methionine kinetics in humans 
 
 
Andreas Schmid Inauguraldissertation, University of Basel Page 82 
 
ratio EtLys/Lys "0" 
Fig. 55: Chromatogram of a control subject after an abstinence period of one month. An EtLys peak is still 
visible, but it is below the limit of quantification. 
 
 
ratio EtLys/Lys 0,019 
Fig. 56: The chromatogram from figure 55 reanalysed after spiking it with 50 µM EtLys 
 
The measured EtLys/Lys ratios in the samples of the alcoholic patients was in a range of 
between 0.01% and 0.06% (table 6). As shown in figure 57 alcohol consumption on a 
daily basis results in an elevated ratio of EtLys and Lys. Except for the sample of MG it 
seems that there might be a tendency towards higher ratios when the imbibed dose is 
augmented. 
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Table 6: Resulting EtLys/Lys ratios of the 6 alcoholic patients and the controls 
Name Sex Alcohol/d [g] Lysarea EtLysarea EtLys/Lys 
AD ♂ 50 112148 536 0.005 
MG ♂ 60 107617 149 0.001 
JJ ♂ 50 110961 521 0.005 
GL ♂ 100 108211 385 0.004 
EW ♀ 100 111101 616 0.006 
BW ♂ 20 109935 343 0.003 
+ ctrl ♂ 50 110320 440 0.004 
- ctrl ♂ 0 105754 n/a 0 
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Fig. 57: The correlation of the amount of alcohol consumed daily and the EtLys/Lys ratio. 
 
No EtLys was found in any of the samples derived from erythrocytes after their lysis and 
the subsequent hydrolysis of the proteins (figure 58). One reason for this finding could be 
that only up to 0.2% of the total haemoglobin is modified by AcHO69. Besides of that 
AcHO modifies mainly N-terminal valine residues of the b-chain103 probably because of 
their free accessibility. There are less Lys residues in haemoglobin (a-chain 7.8%, b- chain 
6.8%) than in albumin (9.9%). Modified Lys residues which only account for a minor 
fraction of AA in haemoglobin may therefore not reach detectable concentrations. 
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Fig. 58: amino acid pattern derived from lysed erythrocytes and subsequent hydrolysis of the proteins 
present. No EtLys could be detected (~ 32 min.) 
 
Discussion 
The present work demonstrates that the first metabolite of alcohol in the body – AcHO – 
forms EtLys in vitro and in vivo. This has been demonstrated by incubation of a-BOC-Lys 
and albumin with AcHO and by detection of EtLys-species in alcohol fed rats, as well as in 
subjects consuming alcohol. A direct comparison with results from other investigators who 
detected AA in vivo by immunologic means was not possible because we were the first to 
determine the ratio of EtLys/Lys as a possible marker of alcohol consumption in plasma 
proteins. Our in vitro results (incubation of albumin with AcHO) generated similar 
amounts of EtLys as others have found before46,131 using radioactive AcHO. The AcHO 
concentrations used for the in vitro experiments were much higher than they can be 
found in plasma. As mentioned above most of the detrimental action of AcHO happens 
inside of the cells and there is no information so far concerning the intracellular AcHO 
concentration. Therefore it can only be speculated whether the AcHO concentrations used 
for the incubation were far from being physiological or not. 
The analysis of EtLys proved to be quite a challenge. The broad spectrum of GC methods 
applied for its detection did not yield results sensitive enough for further analysis in 
plasma proteins where naturally occurring amino acids are present in much higher 
concentrations. 
The LC-MS approach was unsuccessful because of the basic amino acid Arg which in our 
method could not be separated chromatographically from EtLys. Unfortunately EtLys and 
Arg which have identical masses and similar fragmentation patterns co-eluted. Their 
Metabolites of ethanol as markers of alcohol abuse / Glutathione consumption and methionine kinetics in humans 
 
 
Andreas Schmid Inauguraldissertation, University of Basel Page 85 
separation would probably have needed a special HPLC-column which would have 
tolerated separations at pH-values around 11. The MS, which was used as the detector, 
restricted the choice of eluents to organic solvents and water, which in consequence did 
not allow us to isolate and quantify EtLys with the available LC-system. 
 
The HPLC-method which was finally used was able to solve some of the problems stated 
above. We were able to isolate EtLys from the other amino acids, including basic amino 
acids, and we achieved a better sensitivity. 
 
The kinetics of EtLys in proteins in vivo remains to be elucidated. In the rats the 
concentration of EtLys decreased promptly after the feeding of ethanol stopped. There 
was a tendency for the concentration of EtLys in plasma proteins to decrease even before 
the cessation of alcohol feeding. This may be a chance occurrence or may represent an 
adaptive response. Further studies will have to provide an answer to this question. 
 
The samples of the alcoholic subjects and the control subject who drunk under controlled 
circumstances contained small amounts of EtLys. The ratio of EtLys and Lys amounted to 
approximately 0.01, indicating that about 1% of all Lys residues of plasma proteins had 
been altered by AcHO to EtLys. After the control subject quit drinking we could 
demonstrate that EtLys indeed disappeared. 
  
The chromatographic analysis of EtLys by HPLC is a reproducible method that bears the 
potential to open up an area for the development of a new marker of (recent) alcohol 
consumption. 
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Glutathione consumption and methionine 
kinetics in humans 
Numerous functions of glutathione (GSH), the tripeptide consisting of glycine, glutamic 
acid and cysteine (Cys), have been established (for reviews see41,91). Best known is its 
function as a nucleophile that reacts with electrophilic metabolites of endo- and xeno-
biotics to form glutathione adducts. These are excreted after further metabolism to form 
the corresponding cysteine adduct and, in many cases, the N-acetylcysteine adduct (or so 
called mercapturic acid). The conjugation reaction can occur spontaneously but is often 
catalysed by one of the glutathione S-transferases. These enzymes markedly speed up 
the conjugation of electrophiles with GSH and thereby prevent the reaction of potentially 
toxic metabolites with vitally important macromolecules. This is the major mechanism by 
which GSH protects against the hepatotoxic metabolite of paracetamol: GSH traps the 
toxic metabolite N-acetyl-p-benzoquinoneimine (NAPQI). When intracellular GSH is 
depleted, the metabolite binds to critical macromolecules and a process ultimately leading 
to necrosis and apoptosis is set in motion. Although the synthesis of GSH is stimulated 
when its concentration decreases, the availability of precursor amino acids, particularly 
the availability of Cys, is not sufficient in the case of a paracetamol intoxication to sustain 
intracellular GSH.  
GSH not only traps electrophilic metabolites, it is also a versatile metal binding ligand and 
plays an important role in the transport of metals, their storage and their excretion. GSH 
is the most abundant intracellular non-protein thiol and as such is critical for the 
maintenance of the intracellular redox homeostasis26. Cells – and particularly their 
mitochondria – are continuously exposed to reactive oxygen species. The reduction and 
detoxification of hydrogen peroxide and other peroxides by GSH is catalysed by 
glutathione peroxidase. The resulting glutathione disulfide (GSSG) is rapidly reduced back 
to GSH by glutathione reductase with nicotinamide adenine dinucleotide phosphate 
(NADPH) utilized as the reducing equivalent. By maintaining the proper redox status of 
the cell and protecting it from reactive oxygen species, GSH plays a central role in the 
delicate balance between cell death and cell survival. Recent studies have shown that 
depletion of GSH sensitises cells to pro-apoptotic stimuli and activates programmed cell 
death40. Conversely, heat shock proteins that are induced during stress responses 
increase the intracellular concentration of GSH and facilitate the inhibition of apoptosis76. 
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GSH also modulates gene expression and the activation of transcription factors and 
thereby plays an important role in organ regeneration37. 
Finally, GSH appears to regulate the activity of some transporters of organic solutes and 
ion channels. Since many drugs, in particular chemotherapeutic agents used in oncology, 
are exported by such pumps, GSH depletion could inhibit their excretion and potentially 
enhance their toxicity72.   
The maintenance of adequate intracellular concentrations of GSH is therefore crucial for 
cellular function, and the organism must have the capacity to replenish GSH stores when 
the tripeptide is depleted. Cys is the rate limiting amino acid in the synthesis of GSH. The 
intracellular pool of free Cys, however, is one order of magnitude smaller than the pool of 
GSH. Therefore, the Cys required for the synthesis of GSH must be provided by increased 
uptake of circulating Cys, protein catabolism or from methionine (Met) via the 
transsulfuration-pathway. In rats, the major source of Cys utilized for the synthesis of 
GSH following its depletion by a large dose of paracetamol originates from Met22,118,126. 
The source of Cys in a similar situation in humans is not known. The aim of the  present 
study was to estimate the contribution of Met as a source of Cys for GSH synthesis in 
humans in a situation where the synthesis of GSH is stimulated. 
Met is one of nine essential amino acids for humans, i.e. the body is not able to 
synthesise it. The amino acid is needed for the maintenance of the biochemical 
equilibrium and therefore has to be provided with food. The free Met pool in the body has 
a concentration of 20-25 µmol/kg48. Met is needed for the synthesis of proteins – every 
newly synthesised protein starts with a Met – and it is important for methylating reactions 
in the body (via S-adenosyl-methionine (SAM)). A small fraction of Met may also undergo 
transamination. The pool of Met is maintained by protein breakdown, by remethylation of 
homocysteine in the methionine cycle and by dietary intake. 
The first step in the methionine cycle is a condensation of Met with adenosine 
triphosphate (ATP) catalysed by methionine-adenosyl-transferase leading to SAM. This is 
an important methyl-donating molecule for many reactions. The utilization of SAM for 
transmethylation reactions yields S-adenosyl-homocysteine (SAH) and, following the loss 
of the adenosyl-group, homocysteine. The cycle is completed by remethylation of 
homocysteine to Met (figure 59). This reaction may occur via methionine-synthase that 
uses the methyl-group of 5-methlytetrahydrofolate or by the demethylation of betaine. 
The latter reaction occurs only in the liver whereas the former one occurs in all tissues2. 
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Fig. 59: The methionine cycle. SAH = S-adenosyl-homocysteine, SAM = S-adenosyl-methionine, THF = 
tetrahydrofolate (from 67) 
 
Approximately 45% of homocysteine originating from the breakdown of SAH are 
remethylated to yield Met112. The remaining 55% enter the transsulfuration-pathway 
where Cys, the rate limiting amino acid in the synthesis of GSH, is one of the products 
(figure 60).  
 
 
Fig. 60: The transsulfuration pathway of homocysteine. GSH = glutathione (from 67) 
 
The study of GSH metabolism in humans is complex since the tripeptide is mainly 
intracellular and cells of interest, such as hepatocytes, are not readily accessible. 
Moreover, humans can not be exposed to any risks by excessive depletion of their GSH 
stores. One way to safely stimulate GSH turnover and thereby study some of the 
regulatory mechanisms in humans is the administration of therapeutic doses of 
paracetamol. 
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Approximately 5% of a therapeutic dose of paracetamol are normally activated by the 
cytochrome P450 isoenzyme 2E1 to the toxic metabolite NAPQI which is detoxified by 
GSH and subsequently excreted as thiol metabolites of paracetamol25,77. When large 
amounts of NAPQI are formed and the available GSH is consumed, the rapid resynthesis 
of GSH is essential to prevent binding of NAPQI to cellular proteins and thereby affecting 
their function. 
The turn-over of the methionine cycle can be monitored by labelling Met with stable 
isotopes. In our case the S-methyl-group was 13C-labelled. Labelled Met is incorporated 
into SAM and the labelled methyl-group is transferred to an acceptor in the course of the 
methionine cycle. The resulting methylated acceptor is degraded over several steps to 13C 
enriched CO2, which was monitored as a surrogate marker for the use of Met when there 
is an increased demand for homocysteine. For the generation of Cys via the 
transsulfuration pathway the methionine cycle is stimulated resulting in an increased 
formation of CO2. 
In order to determine the reaction of the body to an increased consumption of GSH we 
carried out an open cross-over study. In a first period the methionine metabolism was 
monitored in each participant after oral administration of 2 mg/kg body weight of L-[S-
13C]methionine. Blood and breath samples were collected for 2 and 3 hours respectively 
after Met ingestion. In a second period 2 g of paracetamol were given orally (Dafalgan 
Odis®) 30 minutes before the administration of the labelled Met. 
Using a similar approach but with double-labelled stable Met isotopes (L-[S-2H3-1-
13C]methionine) we have recently shown a reduction of the remethylation in patients with 
alcoholic liver disease99 in whom intracellular GSH is often decreased.  
 
Our aim was to investigate the reaction of the methionine cycle under high therapeutic 
doses of paracetamol by determination of the enrichment of 13CO2 in breath and by 
quantifying the metabolism of Met and of thiols like homocysteine, Cys and GSH in 
plasma. 
 
Material and Methods 
Subjects 
Six healthy male volunteers aged between 29 and 59 years (median 32 years) 
participated in the study which was carried out in the Clinical Investigation Unit (CIU) of 
the university hospital in Bern. They did not take any medication regularly and none drank 
Metabolites of ethanol as markers of alcohol abuse / Glutathione consumption and methionine kinetics in humans 
 
 
Andreas Schmid Inauguraldissertation, University of Basel Page 90 
more than 30 g of alcohol per week. All participants were carefully informed of the 
nature, purpose and possible risks of the study before they gave written consent to 
participate. The local ethics committee approved the protocol and consent form. In three 
additional subjects the same protocol was followed but only breath samples were 
collected. 
 
Study Protocol 
The subjects were studied on two occasion one week apart. After fasting overnight, the 
subjects were admitted to the unit in the early morning, and an intravenous catheter was 
inserted into a forearm or hand vein. After plasma and breath samples for baseline 
measurements had been obtained, the subjects ingested 2 mg/kg (13 µmol/kg) of L-[S-
13C]methionine (MassTrace, Woburn, MA) dissolved in 30 mL of water. Further blood and 
breath samples were then obtained at intervals over the following 2 hours while the 
subjects were at rest.  
Blood samples were drawn into precooled 5-mL ethylenediaminetetra-acetic acid (EDTA)-
coated containers (S-Monovette, Sarstedt, Nümbrecht, D) and were immediately 
centrifuged; the separated plasma samples were either kept on ice until further analysis 
or were immediately derivatised for the determination of free thiols. Breath samples were 
collected through a straw into glass vials that were immediately sealed airtight. After 
obtaining the last sample, plasma samples were stored at –20°C and breath samples at 
room temperature until further analysis. 
The study was repeated following the ingestion of 2 grams of paracetamol (Dafalgan 
Odis®) 30 minutes prior to the administration of the labelled Met. 
 
Analytical Methods 
Methionine 
Met was isolated from plasma by anion-exchange chromatography. To 500 µL of plasma 
20 µL of ice-cold 15% sulfosalicylic acid were added for deproteinisation, and the mixture 
was centrifuged for 10 minutes at 14000 rpm in an Eppendorf 5415 C centrifuge. To 300 
µL of the supernatant 20 µL of ethionine (500 µM in water) which served as internal 
standard, 1 mL of water and 100 µL of 1 M sodium hydroxide were added. The sample 
was then applied to an anion-exchange column (AG 1-X8, 100-200 mesh, chloride form; 
bed size: 2 mL; BioRad, Hercules, CA), and the column was washed with 7 mL of water 
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and then with 2 mL of methanol. The analytes were eluted with 6 mL of 2 M acetic acid in 
methanol and dried under a stream of air at 40°C. The sample was taken up in 100 µL of 
water and an aliquot of 30 µL was dried under air at 40°C, 30 µL of acetonitrile and 10 µL 
of N-[tert-butyldimethylsilyl]-N-methyltrifluoro-acetamide (MTBSTFA) were added for 
derivatisation and the vial was kept tightly closed for 30 min. at 80°C. 
 
Gas Chromatography 
The tert-butyldimethylsilyl (TBDMS) derivatives of Met were measured by gas 
chromatography-mass spectrometry (GC-MS) with a HP 5890 series II gas chromatograph 
connected to a HP 5971 mass spectrometer operated in the electron impact mode 
(Hewlett-Packard, Palo Alto, CA). Gas chromatographic separation was accomplished on a 
MN Optima 1 12 m x 0.2 mm, 0.35 µm GC-column. The temperature increased from 
110°C (2 min.) to 250°C (3 min.) at a rate of 25°C/min. Injector temperature was set at 
260°C and detector temperature was 300°C. Helium was used as a carrier gas with a total 
flow of 0.9 mL/min. One µL of the derivatives was injected for GC-MS. Met eluted at 5.4 
min. and ethionine at 5.7 min. The TBDMS-derivatives of unlabeled Met, 13C-methionine 
and ethionine were monitored in single-ion monitoring mode at m/z 320, m/z 321 and 
m/z 334, respectively. The monitored masses correspond to the derivates following the 
loss of a tert-butyl group (M -57). The concentrations of endogenous Met was calculated 
from the ratio of the peak areas of TBDMS-Met and TBDMS-ethionine. A typical calibration 
curve of this ratio of ‘Met’ (m/z 320) and ‘ethionine’ (m/z 334) is shown in figure 61. 
Concentrations of 13C-Met were calculated from the enrichment and the endogenous Met 
concentration (figure 62). 
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Fig. 61: typical calibration curve for Met based on the ratio of ‘Met’ (m/z 320) to ethionine (m/z 334) 
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Fig. 62: calibration curve for the enrichment of 13C-methionine (m/z 321) to 12C-methionine (m/z 320) in µM. 
30 µM of 12C Met were mixed with increasing amounts of 13C Met. 
 
13CO2 determination 
13CO2 in breath samples was measured by isotope ratio mass spectrometry with an 
Automated Breath 13Carbon Analyzer (Europa Scientific, Cheshire, United Kingdom). 
 
Determination of thiols in plasma 
Free thiols 
EDTA-coated containers (S-Monovette, Sarstedt, Nümbrecht, D) were prepared by adding 
160 µL of a L-serine-borate solution before a blood sample of 4 mL was obtained. The L-
serine-borate solution was prepared by dissolving 0.11 g of L-serine and 0.38 g of di-
sodiumtetraborate decahydrate in 20 mL of 0.5 M phosphate-buffer pH 6.2. L-serine-
borate inhibits gGT which could destroy GSH ex vivo. The blood was mixed well and 
centrifuged at 3000 rpm for exactly 3 minutes. Immediately afterwards 50 µL of the 
plasma were added to an Eppendorf tube containing 50 µL of Tris-buffer, 20 µL of 10 mM 
monobromobimane (MBB)-solution and 10 µL of internal standard and mixed well. After 5 
minutes of incubation at room-temperature the reaction was stopped by adding 20 µL of 
perchloric acid 20%. The samples were stored at –80°C until their analysis by HPLC. 
The Tris-buffer was prepared by dissolving Tris-HCl (24.23 g/L) and sodium-EDTA (1.871 
g/L) and adjusting of the solution to pH 8,5. The MBB was dissolved in acetonitrile. For 
the internal standard 3.73 mg of penicillinamine were dissolved in 10 mL of water. 20 µL 
thereof were mixed with 480 µL of Tris-buffer and 20 µL of 10 mM MBB-solution and 
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incubated for 5 minutes at room-temperature before stopping the reaction by adding 20 
µL of perchloric acid 20%. 
Two Waters series 510 pumps with a Waters Automated Gradient Controller, a Waters 
717plus Autosampler and a Merck/Hitachi F 1000 Fluorescence Spectrophotometer were 
used for HPLC analysis. For the separation of the MBB derivatives a Macherey Nagel EC 
250/4 Nucleosil® 100-7 C18 column was used. Eluent A was acetonitrile and eluent B a 
mixture of 1 g/L octanesulfonic acid and 10 mL/L acetic acid. The gradient used is shown 
in table 7. 
 
Table 7: HPLC-gradient used for the determination of free thiols 
Time [min.] % A % B Curve Flow [mL/min.] 
Initial   9 91 * 1,0 
35 15  85 8 1,0 
40 30 70 6 1,0 
42 50 50 6 1,0 
43   9 91 11 1,0 
 
The run-length was 47 minutes but only every 52 minutes 10 µL of a sample were 
injected for better equilibration of the system prior to the next run. The excitation wave-
length was set at 385 nm and the emission was measured at 490 nm. 
 
Total thiols 
For the total thiols 100 µL of L-serine-borate (see above) were added to the EDTA-
containers (S-Monovette, Sarstedt, Nümbrecht, D). Blood samples were immediately 
centrifuged at 3000 rpm for 10 minutes and plasma was stored at –20° C until 
derivatisation. 
To 30 µL of plasma 30 µL of freshly prepared 9 mM bis(2-mercaptoethyl)sulfone (BMS; 
1.68 mg/mL dissolved in 0.2 M Tris-HCl buffer pH 8.5) were added and incubated at 
room-temperature for 40 minutes. After the addition of 20 µL of 20 mM MBB-solution the 
mixture was incubated for a further 5 minutes at room-temperature before stopping the 
reaction by addition of 50 µL of perchloric acid 20%. These samples were centrifuged for 
10 minutes at 14000 rpm at 4°C. These supernatants were stable for 3 weeks at –20°C. 
 
40 µL of the supernatant were mixed with 10 µL of internal standard and 15 µL thereof 
were injected for analysis by HPLC. For the internal standard 3.73 mg of penicillinamine 
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were dissolved in 10 mL of water. 20 µL thereof were mixed with 480 µL of Tris-buffer 
and 20 µL of 20 mM MBB-solution and incubated for 5 minutes at room-temperature 
before stopping the reaction by adding 20 µL of perchloric acid 20%. 
A Waters 600 series HPLC pump was used together with a Waters 600 E system 
controller, a Waters 717plus Autosampler and a Merck/Hitachi F 1000 Fluorescence 
Spectrophotometer for HPLC analysis. For the separation of the reduced thiols a MN ET 
250/4 Nucleosil® 100-5 C18 column was used. A gradient of eluent A (acetonitrile) and 
eluent B (1 g/L octanesulfonic acid and 10 mL/L acetic acid) was used as shown in table 
8. 
 
Table 8: HPLC-gradient used for the determination of total thiols 
Time [min.] % A % B Curve Flow [mL/min.] 
Initial   9 91 * 1,0 
35 13 87 9 1,0 
45 30 70 6 1,0 
52 45 55 6 1,0 
57   9 91 11 1,0 
 
The run-length for the analysis of total thiols was 65 minutes and samples were injected 
every 70 minutes. The excitation wave-length was set at 385 nm and the emission was 
measured at 490 nm. 
 
Paracetamol in plasma 
50 µL of plasma were mixed with 30 µL of internal standard, 120 µL of perchloric acid 
10% and 100 µL of water. After mixing well the samples were centrifuged for 10 min. at 
4°C and 14000 rpm in a Eppendorf 5415 C centrifuge. 
The internal standard consisted of 3-aminophenol. 2.5 mg thereof were dissolved in 2.5 
mL of perchloric acid 10% and diluted to a final concentration of 200 µg/mL with 
perchloric acid 10%. 
For the HPLC a Waters 600 series pump, a Waters WISP 712 injector, and a Spectroflow 
773 detector was used. The separation was carried out on a MN CC 150/4.6 Hypersil 10-3 
ODS column. A 50 mM KH2PO4 solution containing 5% of methanol was used as eluent. 
The flow was 0.7 mL/min. The detection wavelength was 242 nm. Each run lasted for 22 
min. 
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Calculations 
Pharmacokinetic analysis 
The exhaled 13CO2 was calculated from the measured enrichment and assuming a 
constant endogenous CO2 production of 0.14 mmol/kg.min115 using standard formula. The 
area under the plasma concentration time curve of 13C-Met was calculated using the 
trapezoidal rule. Mean transit time (MTT) was calculated as area under the moment 
curve, AUMC, divided by AUC of 13C-Met (m/z 321). If the mean appearance time of tracer 
in the circulation, i.e. the rate of absorption, is constant, MTT provides an estimate of the 
rate of elimination. Oral clearance was calculated as dose divided by AUC. ‘Breath 
clearance’, i.e. the amount of Met metabolised to CO2 and exhaled in breath relative to its 
plasma concentration was calculated as the amount of 13CO2 appearing in breath divided 
by the AUC of 13C-Met in plasma. 
 
Statistical Methods 
All data are presented as mean ± standard error (SE) unless stated otherwise. Student’s 
paired t-test was used to assess the statistical significance of differences between the 
period with and without paracetamol. A p value <0.05 was considered statistically 
significant. Statistical analyses were performed with the aid of the software program 
Sigma Stat (Jandel Scientific Co., San Rafael, CA, USA). 
 
Results 
The concentration of endogenous i.e. unlabelled Met in plasma during the two study 
periods is shown in figure 63. The plasma concentrations did not vary significantly 
following the administration of labelled Met with and without paracetamol. 
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Fig. 63: concentration of 12C Met in the presence (triangles) and absence (circles) of paracetamol. Mean±SE, 
n=6 
 
The time course of the plasma concentration of 13C-Met in the presence and absence of 
paracetamol is shown in figure 64. There was no statistically significant difference at any 
time point between the two study periods. The oral clearance of labelled Met and its 
mean residence time were not different with and without paracetamol (figure 65). 
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Fig. 64: concentrations of 13C Met in the presence (triangles) and absence (circles) of paracetamol. Mean±SE, 
n=6 
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Fig. 65: oral clearance of 13C-Met and its mean residence time (MRT) with and without paracetamol. The 
graphs show the values of the six individuals and the mean with its standard error. 
 
The time course of the exhalation of 13CO2 is shown in figure 66. Again, the time courses 
with and without paracetamol were essentially the same. Consequently, the fraction of 
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the administered dose exhaled as CO2 within 2 hours and the breath clearance were 
identical in the two study periods (figures 67 and 68).  
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Fig. 66: time course of 13CO2 exhalation with (triangles) and without (circles) paracetamol over two hours 
shown as mean ± SE. n = 6 
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Fig. 67: the percentage of the dose of 13C-Met exhaled as 13CO2 of the nine individuals with and without 
paracetamol (mean ± SE) 
Metabolites of ethanol as markers of alcohol abuse / Glutathione consumption and methionine kinetics in humans 
 
 
Andreas Schmid Inauguraldissertation, University of Basel Page 99 
 
Paracetamol
without with 
Br
ea
th
 C
le
ar
an
ce
 m
l/m
in
0
100
200
300
400
500
 
Fig. 68: the breath clearance of 13C-Met of the six individuals with and without paracetamol (mean ± SE) 
 
The time courses of free and total GSH, Cys and homocysteine in plasma are shown in 
figures 69 and 70. No free homocysteine was detectable. 
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Fig. 69: total thiols as mean ± SE with (triangles) and without (circles) paracetamol 
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Fig. 70: free thiols as mean ± SE with (triangles) and without (circles) paracetamol 
 
The plasma concentration of paracetamol amounted to 0.13 +/- 0.013 µmol/L at 30 
minutes after ingestion (just before the ingestion of the labelled Met). 
 
Discussion 
Following the oral ingestion of 13C-Met approximately 12% of the administered dose 
appear in breath in form of 13CO2 within 2 h of ingestion. This provides a minimal estimate 
of the metabolism of Met since only a fraction of administered labelled bicarbonate 
appears in breath as CO2123, indicating that a substantial fraction of the one carbon pool is 
not eliminated via breath. The amount of CO2 appearing in breath after administration of 
S-methyl-labelled Met was similar to the amount exhaled after administration of Met 
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labelled in the carboxyl group ([1-13C]-Met) where approximately 11% of the administered 
dose appeared in breath within 2h99.  
When the administered Met is labelled in the S-methyl group the 13CO2 appearing in 
breath reflects mainly the fraction of Met that has been incorporated into SAM and has 
been demethylated to SAH. The subsequent fate of the homocysteine originating from 
SAH, either transsulfuration, remethylation, transamination etc. cannot be deduced. When 
the administered Met is labelled in the carboxyl group the 13CO2 appearing in breath 
mainly arises either from transsulfuration of homocysteine to Cys, decarboxylation of SAM 
or transamination and decarboxylation of Met. Decarboxylation of SAM is a minor pathway 
in healthy subjects75. Only negligible amounts of 13CO2 arise from transamination in 
humans14,15. It has been estimated that the transsulfuration pathway accounts for 
approximately 13% to 17% of Met turnover32,74,123,133. The fraction of the administered 
dose exhaled as 13CO2 following [S-13C]-Met would thus be expected to exceed the 
fraction in the case of [1-13C]-Met. That the exhalation of 13CO2 following [S-13C]-Met is 
not considerably higher than following [1-13C]-Met is probably due to the utilization of the 
methyl group of Met for methylation reactions so that only a fraction of the transferred 
methyl groups rapidly enters the one carbon pool to yield 13CO2. Nevertheless, an 
increased utilisation of Met for the synthesis of Cys should result in an increased turnover 
of Met and an increased exhalation of 13CO2. 
The administration of two grams of paracetamol did not have a statistically significant 
measurable effect on the kinetics and metabolism of Met. One possible explanation for 
this negative finding is that in man Met is not an important source of Cys for the synthesis 
of GSH. The Cys consumed in the form of GSH for the detoxification of paracetamol would 
then have to be replaced by Cys equivalents in the circulation since the intracellular 
concentration of Cys is low. Neither free Cys nor small molecular cysteine disulfides, 
mostly cystine, however, exhibited a measurable decrease during the study, thus arguing 
against this hypothesis. An alternative explanation may be that the pool of hepatic GSH is 
not stressed to the extent where a measurable effect on Met kinetics can be expected.  
Approximately 5% of a dose of paracetamol are metabolised to GSH adducts and their 
metabolites90,93. Thus, 2 g, corresponding to 13.2 mmol of paracetamol will consume 
approximately 0.7 mmol of GSH. A normal liver of 1.5 kg contains approximately 6 mmol 
of GSH. In a static system the consumption of approximately 10 % of the pool of GSH 
would be expected to have a measurable effect. However, the turnover of GSH is quite 
high even in the absence of paracetamol and has been estimated at 20–30 µmol/min, 
corresponding to approximately 43 mmol or 14 g per day13,19. This represents a minimal 
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estimate of the total synthesis of GSH, since it does not account for the intracellular 
consumption of GSH and its secretion into compartments other than the circulation, such 
as bile and epithelial lining fluid of the lungs. An additional 0.7 mmol during the hour 
when most of the metabolism of the administered paracetamol will take place may not 
have a measurable effect on the turnover. 
In previous studies the ingestion of the same dose of paracetamol had a measurable 
effect on the concentration of circulating GSH19,62. GSH decreased moderately and 
recovered within 2-3 h consistent with a paracetamol-induced consumption of GSH and its 
resynthesis. No such change in either free or total GSH in plasma was seen in the six 
subjects participating in the present study. Except for the use of a different formulation of 
paracetamol the experimental design and the analytical methods were similar. The 
concentrations of paracetamol in plasma were not measured in the previous studies and 
might have been higher, although the formulation used in the present study is thought to 
release paracetamol rapidly and completely. Alternatively, the stress on GSH pool 
produced by the 2 g of paracetamol may not have been sufficient in these mostly young 
and healthy volunteers to measurably decrease circulating GSH and Cys. 
In summary, the administration of 2 g of paracetamol to healthy subject does not 
measurably stimulate the oral clearance of Met and does not increase the utilisation of 
Met for GSH synthesis via the transsulfuration pathway. 
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